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iAbstract
Reliability of the measure of precision of the estimate is crucial; a correct value of the
standard error of the point estimate entails that the resulting signiﬁcance of the analy-
sis is correctly stated and that conﬁdence intervals have correct coverage probabilities.
Stating an incorrect precision, on the contrary, can often result in biased and mislead-
ing results. In particular, in ﬁxed-eﬀects meta-analysis the overall estimator usually
used in practice tends to have a variance higher than the optimal one even though this
appears to be lower, just by chance.
In performing a ﬁxed-eﬀects meta-analysis, individual treatment estimates are weighted
proportionately to the precision of the study. Such weighting is optimal only under the
assumption that variances are known, which is never the case in practice. As a con-
sequence, the estimator is sub-optimal and the resulting meta-analysis overstates the
signiﬁcance of the results: in particular, overstatements are dramatic when we sum-
marise studies with small number of patients. Focusing the attention to the ﬁxed-eﬀects
model, the main aim of this thesis is to investigate the behaviour of the precision of
the overall estimator under diﬀerent circumstances in order to assess how biased and
incorrectly reported the overall variance of the commonly used estimator is and also to
highlight in which circumstances improved estimates are deemed necessary.
In ﬁxed-eﬀects meta-analysis, problems are related to poor estimates of the individual
variances σ2
i since these values are imprecise and both θ (the point estimator) and V
(the overall variance estimator) depend upon them. Poorly estimated study variances
can lead to the overall estimate of the variance of the treatment eﬀect being badly
underestimated. In order to evaluate the circumstances in which the imprecision in
the estimates of σ2
i badly aﬀects V, a number of simulations in diﬀerent settings were
performed. Under both the assumption of common and uncommon variance of the
observations at the patients level, the average total number of patients per study plays
an important role and this appears to be more important than the total number of
each single study. Moreover, the allocation of patients per arm does not seem to be
decisive for the estimated overall variance of the estimator even though balanced allo-
cation as well as having roughly the same amount of patients per study yields better
results. Furthermore, true to form, the higher the average number of patients per arm,
iithe closer the estimator is to the optimal one, i.e. the fewer the number of patients,
the less precise the estimates of σ2
i are and the greater the impact is on the results.
Given the imprecision in the estimate of σ2
i , we may severely overstate the precision
of ˆ θ. Better estimation of the variances are therefore investigated. Are there ways to
account for the imprecise estimates of the within-studies variances?
Shrunk variances were considered in order to assess whether borrowing information
across variances would produce an overall variance estimate whose ‘real’ and ‘average’
dispersion were both closer to the optimal value. Combining measurements minimises
the total ‘Mean Squared Error’. Therefore, particularly when the nature of the prob-
lem is not to estimate each expected return separately but rather to minimise the total
impact, shrinkage estimators represent a reasonable alternative to the classical estima-
tors. This approach seems reasonable since the goal of this thesis is to minimise the
real dispersion of the overall variance estimator. Moreover, shrinkage approaches (that
combine variance information across studies and are study-speciﬁc at the same time)
usually perform well under a wide range of assumptions about variance heterogeneity,
behaving well both when the variances were truly constant as well as when they varied
extensively from study to study. In particular, in this thesis the ‘modiﬁed CHQBC
estimator’ suggested by Tong and Wang is used (where CHQBC stands for the James-
type shrinkage estimator for variances initially proposed by Cui,Hwang,Qiu,Blades and
Churchill).
Results obtained via simulations (with diﬀerent patterns for various variance schemes
and diverse average amounts of patients per study), emphasise that the estimator based
on the ‘shrunk variances’ performs better than the one based on the estimated sam-
ple variances. Regardless of the variance structure across studies (homoscedasticity
or uncommon variances), the estimator based on the shrunk variances performs op-
timally, even with an average small number of patients per trial, achieving almost
optimal results even when the variances are strongly heterogenous and without relying
on computational expensive procedures. Chapter 3 shows the results obtained if shrunk
variances are used instead of the declared ones; moreover, this new approach is applied
to some real data-sets showing how the declared variance tends to be higher in all cases
and presumably closer to the ‘real’ optimal value.
Finally, chapter 4 highlights the merits of this new approach to the problem of impre-
cise precision estimates in ﬁxed-eﬀects methods and also looks at the further work that
needs to be done in order to improve results for this and other meta-analytical settings;
this thesis, in fact, only considers the case of continuous normally distributed data ig-
noring binary, ordinal or survival data meta-analyses. Moreover, despite the fact that
the problem of estimating σ2
i is particularly urgent and dramatic in the ﬁxed-eﬀects
model, the estimation of σ2
i might also be expected to inﬂuence random eﬀects coverage
iiiprobabilities especially when all studies in the meta-analysis are small (Brockwell &
Gordon, 2001).
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xChapter 1
Introduction
Meta-analysis is intended to provide the statistical summary of a collection of results
from individual studies for the purpose of integrating the ﬁndings. Data-analysis is
only the last step of a long and complicated research synthesis procedure that involves
a problem formulation stage, a data collection stage and a data evaluation step all of
them necessary to evaluate and decide what reported studies to include in the analysis.
The outcome of a meta-analysis may therefore be a long awaited process.
During the last 20 years or so, literally thousands of meta-analytic papers primar-
ily covering applications in health and medical sciences have been published, making
meta-analysis have a very important role in diverse ﬁelds of applications. Moreover, the
essential character of meta-analysis is quantitative in nature and since this statistical
summary is applied to numerous diverse applications in many ﬁelds, it is essential that
misleading results are not produced. In fact, often, ﬁnal decisions are based upon the
conclusions obtained through such a quantitative research synthesis; small variations
in the outputs can have an important impact and substantial consequences in public
and health planning policies, for instance. Given the length of a meta-analysis and the
impact results may have, precision of the estimates is a crucial point.
There is no empirical nor theoretical basis for preferring the ﬁxed-eﬀects model over
the random-eﬀects model or viceversa. There are some arguments in favour of each
approach which depend on the purpose as well as conceptual diﬃculties linked to both
points of view. This thesis, however, will focus on ﬁxed-eﬀects models, trying to in-
vestigate how reliable and accurate results are. The reason why we will concentrate
attention on ﬁxed-eﬀects meta-analysis is that weights, overall point estimate θ as well
as the precision of the estimate depend entirely and solely upon the ﬁndings of many
empirical studies which are usually assumed to be known. The simplifying assumption
is that the sampling variances of the eﬀect size estimates are known; however, this is
approximately true only when sample sizes are large. It is therefore essential to allow
1for the imprecision of these estimates.
The ordinary method is too sensitive to individual study variances and is negatively
biased when sample sizes are too small. In particular, the precision of σ2
i has a dra-
matic inﬂuence on weights and therefore on V, the overall precision of the estimator
that describes how uncertain we are about the point estimate. Treating σ2
i ’s as known
underestimates V and can lead to a loss of eﬃciency, especially for small trials. When
we consider small sizes, standard errors should not be considered as if they were known,
because this would overestimate precision, leading to unreliable results.
1.1 Aim
Fixed-eﬀects models do not account nor allow for the sampling error in ˆ σ2
i ; however, it
is known that sampling errors are present in practice. When we ignore this problem -
as it happens with the ordinary method – the usual variance estimator performs very
poorly in detecting the true variance of θ and underestimates the true value. Moreover,
the actual variability of the variance estimator is always higher than both the declared
and optimal ones, with a consequent overstatement of the precision of the estimator and
misleading results in the form of too liberal signiﬁcance tests and Conﬁdence Intervals
without correct coverage properties, in particular with small size studies.
The aim of this thesis is therefore to illustrate via simulations - and calculations where
possible - what circumstances (variance structure across studies at the patient level,
number of studies, allocation per arm, study size) worsen the estimate of the variance of
the overall estimator. Moreover, and more importantly, it will be investigated whether
a diﬀerent method, able to be accurate and ﬂexible at the same time, exists. In partic-
ular, an estimator whose variance does not diverge substantially from the optimal value
both on average and in practice is highly wanted and warmly recommended. This would
guarantee both more accurate statements about the precision of the point estimate and
conﬁdence intervals more likely to have the correct nominal coverage probabilities.
2Chapter 2
Meta-Analysis is biased
2.1 Meta-Analysis
“Meta-analysis is a quantitative approach for systematically combining the results of
previous studies in order to arrive at summary conclusions about the body of research”
(Petitti, 1994, pg. 4,15). The need for such a quantitative review and synthesis of re-
sults of related but independent studies became particularly acute in the social sciences
in the mid-70s, when the narrative literature reviews were perceived selective in the
inclusion of studies and subjective in their weighting (Petitti, 1994). Since then, uti-
lization of meta-analytic techniques to combine results and information from separate
quantitative investigations has become increasingly common, and statistical methods
for its application have been further explored and developed. “Over the past 20 years
the number of published meta-analyses and discussions on meta-analysis methodology
has dramatically increased. This has occurred particularly in the areas of medical
and epidemiological research” (Brockwell & Gordon, 2001, pg. 825). The popularity
of meta-analysis is due to its overall goal: integrated analysis has “more statistical
power to detect a treatment eﬀect than an analysis based only on one study” (Nor-
mand, 1999, pg. 321). Furthermore, “when several studies have conﬂicting conclusions
a meta-analysis can be used to estimate an average eﬀect or to identify a subset of
studies associated with a beneﬁcial eﬀect” (Normand, 1999, pg.322). Meta-analysis
can be of great advantage in situations for which individual outcomes are diﬃcult to
interpret or when treatment eﬀects are small or not signiﬁcant in each study alone.
“Owing to this rapid rise in the popularity of meta-analysis, it is becoming increasingly
important that the methodology and statistics used are sound” (Brockwell & Gordon,
2001, pg. 825).
Consider k separate studies looking at the same clinical question (as, for example,
a comparison between a new medication and placebo) in which each trial treatment is
3estimated in terms of a diﬀerence in means of a quantitative variable. Meta-analysis
can be based on a ﬁxed-eﬀects model (where the inference is conditional on the studies
actually done) or on a random-eﬀects model (where studies are considered a random
sample of some hypothetical population of studies). The two diﬀerent assumptions ad-
dress to two diﬀerent theoretical questions. “The random-eﬀects model is appropriate
if the question is whether the treatment will, on average, have an eﬀect. If the question
is whether the treatment has caused an eﬀect in the studies that have been done, then
the ﬁxed-eﬀects model is more suitable” (Petitti, 1994, pg. 93). Evidently, these dis-
tinct assumptions entail distinct statistical methods; “the random-eﬀects model uses
a two-stage sampling idea, as if we sampled from a superpopulation of studies that
might be carried out and then sampled patients within the studies. Of course, the
real situation is more like a selection of studies that can be carried out” (Mosteller &
Chalmers, 1992, pg. 232).
“The random-eﬀects model in meta-analysis has actually been suggested as a way to
model known diﬀerences between studies such as study-design, diﬀerent within-study
matching protocols, diﬀerent treatment protocols” (treatment doses, lengths, exposures
or intensities, for example), interventions, outcomes studied “or perhaps even gender or
cultural diﬀerences between study participants” (Biggerstaﬀ & Tweedie, 1997, pg. 753).
In practice, there are so many diﬀerent approaches to conducting a study that there
are many diﬀerent potential treatment eﬀects that could arise. “Such diversity is com-
monly referred to as (methodological or clinical) heterogeneity (τ2) and may or may
not be responsible for observed discrepancies in the results of the studies. Addressing
such heterogeneity has been and still is one of the most troublesome aspects of many
systematic reviews” (Higgins & Thompson, 2002, pg. 1539,1540) as its magnitude can
inﬂuence the conclusions of the meta-analysis. Quantifying the amount of heterogene-
ity is therefore one of the most important aspects of systematic reviews.
Whether ﬁxed-eﬀects or random-eﬀects models are more appropriate, the choice of
model is very important as this “can lead to noticeably diﬀerent conclusions” (Mengersen
et al., 1995, pg. 38). The impact of the choice of method can be signiﬁcant. Even small
absolute variations can have an important impact and “they may have substantial con-
sequences in arenas such as public policy, health planning and litigation” (Mengersen
et al., 1995, pg. 39). There are conceptual diﬃculties linked to both the ﬁxed-eﬀects
and random-eﬀects points of view: “in both models, it may be diﬃcult to characterize
precisely the universe to which we are inferring” (Normand, 1999, pg. 326). In partic-
ular, random-eﬀects model assumes that the results from the trials are representative
of the results which would be obtained from the total population of centres while, in
reality, centres are not chosen at random. On the other hand, the ﬁxed-eﬀects model
makes the assumption that the characteristics of patients in meta-analytical studies are
4the same as those in the total patient population.
There is no empirical nor theoretical basis for preferring the ﬁxed-eﬀects model over the
random-eﬀects model or viceversa. Nonetheless, despite the long controversial debate
as to the choice of the appropriate model, statisticians’ attention has focused mainly
on the random-eﬀects model that incorporates a parameter explicitly accounting for
the between-trial variability, producing results which can be considered more general-
isable. Mosteller and Chalmers, for instance, “fear that some investigators prefer the
ﬁxed-eﬀects approach because it gives narrower conﬁdence limits rather than because
they want to apply their inferences to the particular population sampled” (Mosteller &
Chalmers, 1992, pg. 232). Biggerstaﬀ and Tweedie remark that “the application of the
ﬁxed-eﬀects model in meta-analytic contexts has been called into question” (Biggerstaﬀ
& Tweedie, 1997, pg. 753). Moreover, it is believed that, although random-eﬀects mod-
els are generally conservative since they typically widen conﬁdence intervals and lead
to a lower chance of calling a diﬀerence ‘statistically’ diﬀerent, they give a “much truer
picture of variability both in individual studies and across a set of studies and conse-
quently enable more informed inference” (Mengersen et al., 1995, pg. 41). Normand
notes that “it is almost always reasonable to believe that there is some between-study
variation and few reasons to believe it is zero”. Especially when studies conﬂict, “it
is diﬃcult to ignore the between-study variation” (Normand, 1999, pg. 326). Further-
more, “the test for the heterogeneity for assessing the validity of the ﬁxed eﬀect model
is of limited use, particularly when the total information is low, or when the amount of
information available in each trial is very variable” (Hardy & Thompson, 1998, pg. 853).
Hardy and Thompson believe that “in practical medical research, clinical homogeneity
is rare owing to the nature of the studies and the many variables involved, and a degree
of a statistical heterogeneity may be anticipated” (Hardy & Thompson, 1996, pg. 620).
The ﬁxed-eﬀects approach is “open to criticism and is generally discouraged. A truly
random eﬀects approach estimating τ2, which simpliﬁes to a ﬁxed eﬀects model only if
τ2=0, may therefore be preferable” (Jackson, 2006, pg. 2689).
2.2 The models
In light of the above, attention and energies have focused mainly on random-eﬀects
models and on the quantiﬁcation of the heterogeneity τ2. This thesis, nonetheless, will
focus on ﬁxed-eﬀects meta-analysis. The problem of estimating correct within-study
variances (σ2
i ) is important for both models: it is crucial for ﬁxed-eﬀects models but
it is also expected to have consequences on random-eﬀect models as well. Fixed-eﬀects
models will be preferred in order to simplify the presentation of the problem but the
potential strategies to handle with the imprecision of σ2
i ’s could be applied to both
5models.
Fixed-eﬀects and random-eﬀects statistical methods are outlined brieﬂy below. We
consider the problem of combining information from a series of k comparative clinical
trials, where the data from each trial consists of the number of patients in treatment
and control groups, nT and nC. For simplicity, we assume a series of parallel group
trials. When means, X, in each treatment arm are known, the mean diﬀerence and
the associated measure of precision for each primary study can be calculated. Letting
i index the trials, a potential summary measure is the diﬀerence in means, Yi = XTi
- XCi with standard error ˆ σi, calculated (under the assumption that the variances in
both groups are identical in each study) by
var(Yi) = σ2
i =

σ2
Ti
nTi
+
σ2
Ci
nCi

= S2
i

1
nTi
+
1
nCi

(2.1)
where a common estimate of S2
i based on both σ2
Ti and σ2
Ci is given by
ˆ S2
i =
(nTi − 1)ˆ s2
Ti + (nCi − 1)ˆ s2
Ci
nTi + nCi − 2
(2.2)
where ˆ s2
Ti and ˆ s2
Ci are the treatment and control group sample variances, respectively,
for the ith study and S2
i is the so called ‘pooled variance’.
2.2.1 The ﬁxed-eﬀects model
The ﬁxed-eﬀects model assumes that each study summary statistic, Yi, is a realization
from a population of study estimates with common mean θ, i.e. every study evaluates
a common treatment eﬀect. This means that the eﬀect of treatment, allowing for the
play of chance, was the same in all studies and if all the studies were inﬁnitely large
they would give identical results.
Let θ - the average eﬀect - be the central parameter of interest and assume there are i=
1,2,...,k studies. Assume that Yi is such that E(Yi) = θ (implying that each study has
the same underlying eﬀect) and let σ2
i = var(Yi) be the variance of the summary statistic
in the ith study. Even under a ﬁxed eﬀect model, in order to calculate conﬁdence
intervals for the overall estimate of treatment eﬀect, it is assumed that the observed
eﬀects in each trial are normally distributed and approximately unbiased (which, for
moderately large study sizes, is guaranteed by the central limit theorem). Thus,
Y i ∼ N(θ,σ2
i ) for i = 1,2,...,k
where σ2
i is assumed known and equal to ˆ σ2
i . Making these additional assumptions,
then ˆ θ ∼ N(θ,1/
Pk
i=1 wi) where wi = 1/ˆ σ2
i which allows the calculation of conﬁdence
intervals for θ (Hardy & Thompson, 1998).
62.2.2 The random-eﬀects model
The random-eﬀects model is an alternative approach to meta-analysis that does not
assume that a common (‘ﬁxed’) treatment eﬀect exists; on the contrary, the true treat-
ment eﬀects in the individual studies may be diﬀerent from each other. This means
there is no single number to estimate in the meta-analysis, but a distribution of num-
bers. The random-eﬀects framework postulates that each study statistic, Yi, is a draw
from a distribution with a speciﬁc mean, θi, and variance σ2
i :
Yi | θi,s2
i ∼ N(θi,σ2
i ) for i = 1,2,...,k
where σ2
i = ˆ σ2
i . Furthermore, each study-speciﬁc mean, θi, is assumed to be a draw from
some superpopulation of eﬀects with mean θ and variance τ2, under the assumption
that these diﬀerent true eﬀects are normally distributed, i.e. with
θi | θ,τ2 ∼ N(θ,τ2)
This gives a two stage model:
(
Yi = θi + ei
θi = θ + i
where ei ∼ N(0,σ2
i ) and i ∼ N(0,τ2). The error terms are assumed to be independent.
In this case, the true eﬀect for study i is centred around the overall eﬀect, allowing in-
dividual studies to vary both in estimated eﬀect and true eﬀect. θ and τ2 are referred to
as hyperparameters and represent, respectively, the average treatment eﬀect and inter-
study variation. Given the hyperparameters, the distribution of each study summary
measure, Yi, after averaging over the study-speciﬁc eﬀects, is Normal with mean θ and
variance (σ2
i + τ2). As in the ﬁxed-eﬀects model, θ is the parameter of central interest
as this represents the overall treatment eﬀect (i.e. the average eﬀect size in the popula-
tion); however, the between-study variation, τ2 (often referred to as the heterogeneity
variance) plays an important role. The special case where τ2 = 0 implies that the eﬀect
sizes are homogeneous (θi = θ,i = 1,2,...,k) and the resulting model is the ﬁxed-eﬀects
one. The σ2
i values (the variance of the diﬀerence in means for the ith study) are esti-
mated by the sample variances ˆ σ2
i (see equation 2.1) usually calculated from the data of
the ith observed sample and are treated as known constants. “In practice the variances
are not known so estimated variances ˆ σ2
i are used to estimate both θ and its variance.
Any eﬀect of this is generally ignored in practice” (Brockwell & Gordon, 2001, pg. 826).
72.3 The Usual Meta-Analytical Estimators
In order to account for diﬀerences in sample size and study-level characteristics, a
weighted average diﬀerences of the estimates from each study is taken into account.
The parameter of interest θ is estimated by
ˆ θ =
Pk
i=1 Yi ˆ wi
Pk
i=1 ˆ wi
with ˆ wi = (ˆ τ2 + ˆ σ2
i )−1 (2.3)
where ˆ τ2 is a suitable estimator of the heterogeneity parameter τ2. When a ﬁxed eﬀect
model is considered, weights are equal to the reciprocal of the within-variability, i.e.
ˆ wi = 1/ˆ σ2
i . “Any choice of weight will lead to an unbiased estimate of the common
treatment eﬀect, but wi is generally taken to be the reciprocal of the variance for the
study i. These particular weights provide the most precise estimate of the treatment
eﬀect, that is they minimise the variance of ˆ θ” (Hardy & Thompson, 1996, pg. 619,620),
ˆ V . Furthermore, assuming σ2
i known and equal to ˆ σ2
i for all i implies that
ˆ V = var(ˆ θ) =
1
Pk
i=1 ˆ wi
(2.4)
where ˆ wi = 1/ˆ σ2
i .
2.4 The Heterogeneity Parameter and the diﬀerent meth-
ods of estimation
In light of the above considerations, attention has been paid particularly to estima-
tion of the heterogeneity parameter. There exists an extensive literature about the
estimation of τ2. This parameter can be estimated using diﬀerent methods of estima-
tion: namely, the method of moments estimator by DerSimonian and Laird (DSL –
DerSimonian & Laird (1986)), the variance-component type estimator by Hedges (VC
– Hedges (1983)), the simple heterogeneity variance estimator by Sidik and Jonkman
(SH – Sidik & Jonkman (2005)), the maximum likelihood estimator by Hardy and
Thompson (ML – Hardy & Thompson (1996)) and the approximate restricted maxi-
mum likelihood estimator (REML – Thompson & Sharp (1999)).
The DerSimonian and Laird method of moments estimator is based on the test statistic
of homogeneity originally proposed by Cochran (Cochran, 1937) in 1937. Using the test
statistic
QC =
k X
i=1
ˆ wi(Yi − ˆ θfix)2
where ˆ wi = (ˆ σ2
i )−1 for i = 1,2,...k and where ˆ θfix is the estimator of θ when τ2 is set
equal to zero in equation 2.3, the DerSimonian and Laird estimator has the explicit form
8ˆ τ2
DSL = max



0;
QC − (k − 1)
hPk
i=1 ˆ wi − (
Pk
i=1 ˆ w2
i/
Pk
i=1 ˆ wi)
i



The DSL estimator is unbiased if the study-speciﬁc σ2
i are assumed known and equal
to ˆ σ2
i . The VC estimator is
τ2
V C = max
(
0,
1
k − 1
k X
i=1
(Yi − Y )2 −
1
k
k X
i=1
ˆ σ2
i
)
where Y =
Pk
i=1 Yi/k. The SH estimator is based on weighted least squares, it is simple
to compute and always yields a non-negative estimate of τ2. This is given by
ˆ τ2
SH =
1
k − 1
k X
i=1
ˆ v−1
i (Yi − ˆ θˆ v)2 ,
where ˆ vi = ˆ ri + 1, ˆ ri = ˆ σ2
i /
hPk
i=1(Yi − Y )2/k
i
and ˆ θˆ v =
Pk
i=1 ˆ v−1
i Yi/
Pk
i=1 ˆ v−1
i .
The ML and REML estimators are less simple computationally and require iterative
solutions. The ML estimator can be calculated by iterating the equation
τ2
ML = max
(
0,
Pk
i=1 ˆ w2
i{(Yi − ˆ θ)2 − ˆ σ2
i }
Pk
i=1 ˆ w2
i
)
until it converges, where ˆ θ =
Pk
i=1 ˆ wiYi/
Pk
i=1 ˆ wi and ˆ wi = 1/(ˆ σ2
i + ˆ τ2
ML), given an
initial estimate of τ2. Similarly, the REML estimator is computed using the iterative
equation
ˆ τ2
REML = max
(
0,
Pk
i=1 ˆ w2
i[(k/(k − 1))(Yi − ˆ θ)2 − ˆ σ2
i ]
Pk
i=1 ˆ w2
i
)
,
where ˆ θ =
Pk
i=1 ˆ wiYi/
Pk
i=1 ˆ wi with ˆ wi = 1/(ˆ σ2
i + ˆ τ2
REML).
Despite the number of methods available to estimate τ2, they usually yield similar
estimates of θ; “this may not be surprising because the weighted mean estimator ˆ θ that
is given in equation 2.3 for an overall eﬀect is not particularly sensitive to the estimated
weights” (Sidik & Jonkman, 2005, pg. 374). It is believed that results “are nearly in-
variant with respect to the choice of the between-study variance estimator” (Hartung &
Knapp, 2001, pg. 3876). Moreover, in practice, the point estimates from the 2 methods
(ﬁxed or random-eﬀects) can even vary only slightly from each other. Estimates of τ2
are important for the calculation of ˆ V , the variance of the overall estimate ˆ θ. In fact,
in addition to point estimates, reporting the overall variance of the estimator and a
conﬁdence interval is usually considered a useful habit in order to indicate the precision
of the overall eﬀect estimate and therefore to stress the level of uncertainty about the
point estimate.
92.5 Estimating the variance of the overall eﬀect estimate
ˆ V : an ignored problem
In the random eﬀects model for meta-analysis, an overall eﬀect is usually estimated with
a weighted average of the single eﬀect measurements. Weights are given by the preci-
sion, i.e. by the inverse of the sum of the within-study and between-study variances.
Such weighting is ‘optimal’ provided that the correct variances are used. Nevertheless,
these values are unknown and weights used in practice are obtained by substituting
estimated variances in place of the true ones. “Because of sampling error, however, the
precision will be estimated with some inaccuracy” (Senn, 2000, pg. 546). Hence such a
weighting is not optimal anymore. “Although such weights based on estimated values
are incorrect and stochastic, and may have large errors in some cases, approximate
inference about an overall eﬀect typically ignores completely the errors associated with
estimation of the marginal variances” (Sidik & Jonkman, 2006, pg. 3682). Moreover,
the variance of ˆ θ, V, is often estimated by equation 2.4 obtained by using the estimated
weights ˆ w−1
i = ˆ σ2
i + ˆ τ2 in place of the original ‘correct’ marginal variances, a practice
which fails to account for the error associated with estimated weights. Clearly, if ˆ σ2
i
and ˆ τ2 have substantial errors, then ˆ w−1
i would be a poor estimate of the variance of
each study summary measure; as a consequence, ˆ V could be unreliable as an estimator
for the variance of θ. The accuracy of the estimated values of σ2
i and τ2 is therefore
decisive: both the variance and the conﬁdence intervals of θ may be considerably af-
fected by using diﬀerent methods of estimating τ2.
In practice, the point estimates from the two methods (i.e. ﬁxed and random eﬀects
models) can even vary only slightly from each other, but the random-eﬀects model
leads to wider conﬁdence intervals for the overall treatment eﬀect. However, in the
calculation of ˆ θ and var(ˆ θ), since both τ2 and σ2
i are assumed known when in practice
they both are estimated, the conﬁdence interval is still too narrow. The imprecision
of the estimates of both τ2 and σ2
i should be considered. In general, random-eﬀects
estimators tend to weight studies more equally, because of the presence of a common
variance τ2 contributing to the weights. In the case where the relative weight of each
single trial is determined more by the value of τ2, it may be acceptable to treat the
standard errors as if they were known. Nonetheless, when σ2
i ’s have a consistent in-
ﬂuence on the weights, it is essential to allow for the imprecision of these estimates,
whether ﬁxed or random-eﬀects analyses are used. In particular, in ﬁxed-eﬀects mod-
els both the weights and the variance of the overall estimator depend solely upon the
within-study variances σ2
i . Hence, the precision with which σ2
i ’s are estimated will have
a dramatic inﬂuence on weights and therefore on the overall precision of the estimator.
Treating σ2
i ’s as known particularly in ﬁxed-eﬀects analysis overestimates the precision
and can lead to a loss of eﬃciency, especially for small trials. This should not be simply
10ignored. As a consequence, this project will focus on the precision of estimates of σ2
i
in ﬁxed-eﬀects meta-analysis.
Problems related to poor estimates of σ2
i have been addressed several times in the
literature and better estimates of var(Yi) have been advocated by a number of authors.
DerSimonian and Laird themselves warned the reader that in their work sampling vari-
ances were “assumed known even though in reality these were estimated from the data”
and exhorted to do “further research” in this area and to investigate diﬀerent methods
of calculating the variances (DerSimonian & Laird, 1986, pg. 187). Viechtbauer recalls
that all the methods brieﬂy cited above concentrate on the study of τ2 given the sim-
plifying assumption that the sampling variances of the eﬀect size estimates are known.
“This is only approximately true when the within-study sample sizes are large (in this
case, ˆ σ2
i ≈ σ2
i ). On the other hand, when the within-study sample sizes are small, then
the error in the ˆ σ2
i values cannot be simply ignored. A meta-analysis of a large num-
ber of studies with small sample sizes yields coverage probabilities that deviate quite
substantially from the nominal level” (Viechtbauer, 2007, pg. 46, 47). Both random
and ﬁxed-eﬀects models do not account nor allow for the sampling error in ˆ σ2
i which
is present in practice. “Inference is carried out ignoring the sampling errors in the
individual study variances. Estimated values ˆ σ2
i are used without modiﬁcation to the
form of ˆ θ, its variance or distribution” (Brockwell & Gordon, 2001, pg. 837). Given the
imprecision in the estimate of σ2
i , we may be severely overstating the precision of the
estimated overall eﬀect size. Conﬁdence intervals for σ2
i could facilitate such sensitivity
analyses by suggesting a possible range of σ2
i values one should consider. Conﬁdence
intervals may become anticonservative especially with increasing number of trials and
small sample sizes (Knapp et al., 2006). In particular, the fewer the number of patients
the less precise will be the estimate of σ2
i , and this additional uncertainty would there-
fore be expected to have a great impact on the results (Hardy & Thompson, 1996).
The problem of estimating σ2
i ’s is particularly urgent and dramatic in the ﬁxed-eﬀects
model, even though “the estimation of σ2
i might also be expected to inﬂuence random
eﬀects coverage probabilities” especially when all studies in the meta-analysis are small
(Brockwell & Gordon, 2001, pg. 837).
Consider the case where there are many but small, equally sized trials and homoscedas-
ticity applies (i.e. the variances of sampling errors are identical in each trial). The opti-
mal approach is to weight every single trial equally. Fixed-eﬀects meta-analysis will de
facto weight inversely proportional to the observed variance. In so doing it will produce
an estimator whose true variance is higher than that produced by equal weighting (the
’correct one’) but which will appear to be lower, “claiming to have produced a lower
standard error for what is, in fact, a less precise estimate” (Senn, 2000, pg. 547) . The
11real observed variances will vary and weighting by these values will produce a variance
estimate that is lower than that for the optimal estimator just by chance. However,
the estimator is sub-optimal because its ’true’ variance is higher. Unfortunately, the
resulting meta-analysis overstates the signiﬁcance of the results (Senn, 2000). As a con-
sequence, signiﬁcance tests associated with it are too liberal and conﬁdence intervals
do not have correct coverage properties (cf. the simulation).
“The problem is not severe if individual trials are not small” (Senn, 2000, pg. 547).
On the other hand, when we consider a number of small trials, standard errors should
not be considered as if they were known because this would overestimate precision and
could also lead to unreliable results. Especially in these cases, investigation of better
estimation of the variances is highly recommended and warmly supported.
2.6 Simulations with common variance
2.6.1 Number of Patients per Arm Equal
“Simulation studies use computer intensive procedures to test particular hypotheses and
assess the appropriateness and accuracy of a variety of statistical methods in relation
of the known truth. These techniques provide empirical estimation of the sampling
distribution of the parameters of interest that could not be achieved from a single
study and enable estimation of accuracy measures, such as the bias in the estimates of
interest, as the truth is known” (Burton et al., 2006, pg. 4279).
Consider a meta-analysis of k similar but independent studies. The observations consist
of two sets of independent random variables XTi1,XTi2,...XTinTi and XCi1,XCi2, ...
XCinCi for i=1, 2, ..., k from the treatment and the control groups, respectively. Note
that nTi and nCi are respectively the study speciﬁc sample sizes for the treatment and
the control groups in the ith study, so the total sample size is Ni = nTi+nCi. Suppose
that these two sets of variables have independent normal distributions with diﬀerent
means and equal variances as follows
XTi1,XTi2,..., XTinTi ∼ N(µTi,σ2
Ti)
XCi1,XCi2,...,XCinCi ∼ N(µCi,σ2
Ci)
for i = 1,...,k where σ2
Ti = σ2
Ci
The parameter of interest is the overall mean diﬀerence, denoted by θ. The study
speciﬁc mean diﬀerence is deﬁned as Yi = (µTi − µCi) and is estimated by Yi = XTi −
XCi, where XTi =
PnTi
j=1 XTij/nTi and XCi =
PnCi
j=1 XCij/nCi. We assume that Yi is
such that E(Yi) = θ (each study has the same underlying eﬀect) and that the variance
of the diﬀerence between two independent means based on nTi and nCi observations
respectively is equal to var(Yi) = σ2
i = σ2
Ti/nTi + σ2
Ci/nCi = S2
i (1/nTi + 1/nCi) given
the assumption that S2
i = σ2
Ti = σ2
Ci (i.e. the two groups in the treatment and control
arms have the same variance). For moderately large study sizes, each Yi should be
12asymptotically normal distributed. Thus,
Y i ∼ N(θ,σ2
i ) for i = 1,2,...,k
For the purpose of the simulation a ﬁxed-eﬀects model is considered, that is each study
summary statistic Yi is thought as a realization from a population of study estimates
with common mean θ.
In addition to the point estimate, Conﬁdence Intervals (CIs) for the overall mean dif-
ference (constructed based on the standard normal distribution) are calculated.
“ The coverage probability of a random interval (A,B) for θ is deﬁned as Pr(θ ∈ (A,B))
which –for a nominal 95 per cent conﬁdence interval– should be close to 0.95. The ex-
act coverage can actually only be found if the distribution of the interval is known”
(Brockwell & Gordon, 2001, pg. 831). However, as in this case, the distribution is un-
known; this implies that the coverage probability must be estimated using simulation.
“This is done by simulating a large number of meta-analyses and for each meta-analysis
calculating the appropriate conﬁdence interval” (Brockwell & Gordon, 2001, pg. 831).
The estimated coverage probability is then the proportion of times that the obtained
conﬁdence interval contains the true speciﬁed parameter value θ. “The coverage should
be approximately equal to the nominal coverage rate, e.g. 95 per cent of samples for
the 95 per cent conﬁdence intervals, to properly control the type I error rate for testing
a null hypothesis of no eﬀect. Over-coverage suggests that the results are too conser-
vative as more simulations will not ﬁnd a signiﬁcant result when there is a true eﬀect
thus leading to a loss of statistical power with too many type II errors. In contrast,
under-coverage (where the coverage rates are lower than 95%) is unacceptable as it
indicates over-conﬁdence in the estimates since more simulations will incorrectly detect
a signiﬁcant result, which leads to higher than expected type I errors”(Burton et al.,
2006, pg. 4287).
The coverage probability is usually dependent on the parameters of the model and so
the coverages presented are estimated for a range of values of S2
i and Ni. The value
of θ is nevertheless irrelevant as “the procedure is invariant with respect to a location
shift” (Brockwell & Gordon, 2001, pg. 831). For all simulations we use θ = 3. The data
for each meta-analysis is simulated using the ﬁxed-eﬀects model described above (i.e.
Yi = θ+ei), assuming normal errors ei with zero mean and variances σ2
i . The coverage
probability is then estimated by simulating 10000 meta-analyses. The number of runs
was set to 10000 in order to reduce the standard error of the simulation process for the
nominal 95% coverage probability (cp) to 0.002179 (SE(cp)=
p
cp(1 − cp)/M) without
being computationally expensive. “A possible criterion for acceptability of the coverage
is that the coverage should not fall outside of approximately two SEs of the nominal
coverage probability (cp)” (Burton et al., 2006, pg. 4287); therefore, in our simulations
between 9457 and 9543 of the 10000 conﬁdence intervals should include the true value.
13The simulations are implemented using a programme in R, with each simulation gen-
erating nTi and nCi observations from normal distributions with mean µTi and µCi =
µTi+θ respectively and variance S2
i . This procedure is repeated k times and the data is
then used to calculate the ﬁxed-eﬀects estimates for θ and the corresponding conﬁdence
interval.
In order to simplify the situation, let us assume that homoscedasticity applies, i.e.
S2
i = S2 for all i. Secondly, even if it is far from reality, we assume that all the studies
have exactly the same size (n = nTi = nCi). This is just to give an indication of what
happens in the case we consider a number of studies all of them with few patients in-
volved; such assumption should therefore only be used as a rough guide of what would
happen in an unlikely but still possible situation (large numbers of big studies is not a
common occurrence in meta-analysis either).
Each estimated signiﬁcance level is based on 10000 independent replications of the
same model and the signiﬁcance level is α = 0.05. We discuss the meta-analytical
combination of the results of k= 10, 15, 20, 35 clinical trials and Ni = 10, 16, 20, 30,
40, 60, 100 patients (i.e. as sample sizes we examine (nTi,nCi) = (5,5),(8,8), (10,10),
(15, 15), (20,20), (30,30) and (50, 50)). As regards the variances, we consider S2 = 1.
With this choice of these patterns we are able to give an impression about the general
attitude of the ﬁxed-eﬀects meta-analysis when both the number of studies and the
sample size change. We will summarise the estimates once all simulations have been
performed. As in many published simulation studies, the average estimate of interest
(i.e. the overall variance of the estimator) over the M simulations performed will be
reported as a measure of the ‘declared’ estimate of interest. Similarly, as an assessment
of the uncertainty in the estimate of interest between simulations, the variance of the
estimates of the overall variance of the estimator from all simulations will be calculated.
Moreover, in order to evaluate the performance of the obtained results from the dif-
ferent scenarios and approaches being studied, the coverage of the conﬁdence intervals
will be be considered as a measure of the performance and precision of the methods.
When judging the performance of diﬀerent methods, some argue than having less bias
is more important than producing a valid estimate of sampling variance (Burton et
al., 2006). In our case, not only has the empirical estimated coverage probability to
correspond to the nominal value, but also- and in particular- the ‘declared’ precision
as well as the ‘real’ dispersion of the overall variance of the estimator should be close
to the theoretical ‘optimal’ one. The dispersion of the variances around the optimal
value will be a good way to assess the goodness of the methods used: both the average
declared variances and in particular the actual variances should be close to the optimal
‘real’ value.
14In particular, when we perform meta-analysis, we consider the estimator
θ =
Pk
i=1 wiYi
Pk
i=1 wi
where wi = (σ2
i )−1
The variance of such estimator, V, is equal to
V = var(θ) =
1
Pk
i=1 wi
The demonstration is as follows
V = var(θ) = var
 Pk
i=1 wiYi
Pk
i=1 wi
!
=
Pk
i=1 w2
iV ar(Yi)
(
Pk
i=1 wi)2 =
Pk
i=1 w2
iσ2
i
(
Pk
i=1 wi)2
=
Pk
i=1( 1
σ2
i
)2σ2
i
(
Pk
i=1 wi)2 =
Pk
i=1 wi
(
Pk
i=1 wi)2 =
1
Pk
i=1 wi
given that var(Yi) = σ2
i and that wi = 1/σ2
i . However, strictly speaking, var(θ) is the
‘true’ variance of the ‘correct’ estimator only when σ2
i ’s are known. When estimated
weights are used both to determine θ and its variance, the equality is not valid anymore.
Furthermore, if we assume that weights are ﬁxed constants as they should be in this
simulation scheme (i.e. wi = 1/k), we obtain
V = var(θ) = var
 Pk
i=1 wiYi
Pk
i=1 wi
!
=
Pk
i=1 w2
iV ar(Yi)
(
Pk
i=1 wi)2 =
1
k2
k X
i=1
var(Yi)
and in our simulation, as both the sample sizes for the treatment and the control groups
are identical, it develops into
var(θ) =
2S2
kn
where n = nTi = nCi
where S2 is the variance of each arm (i.e. S2 = σ2
Ti = σ2
Ci), k is the number of trials
considered and n is the number of patients per arm. This is the ‘optimal’ value of the
variance of θ provided that
σ2
i = var(Yi) =

1
nTi
+
1
nCi

(nTi − 1)σ2
Ti + (nCi − 1)σ2
Ci
(nTi − 1) + (nCi − 1)
=
=

2
n

2(n − 1)S2
2(n − 1)
=
2S2
n
given n = nTi = nCi, S2 = σ2
Ti = σ2
Ci
In practice, we use ˆ S2
i (see equation 2.2) and therefore ˆ σ2
i instead of the ‘true’ σ2
i .
Therefore, all the relationships described above hold if and only if σ2
i is perfectly es-
timated by ˆ σ2
i . This is hardly the case. As a consequence we usually end up considering
the estimator
ˆ θ =
Pk
i=1 ˆ wiYi
Pk
i=1 ˆ wi
15and the variance of ˆ θ, ˆ V , is estimated by
ˆ V =
1
Pk
i=1 ˆ wi
with ˆ wi = 1/ˆ σ2
i
where
ˆ σ2
i =

1
nTi
+
1
nCi

ˆ S2
i =

1
nTi
+
1
nCi

(nTi − 1)ˆ s2
Ti + (nCi − 1)ˆ s2
Ci
(nTi + nCi − 2)
where ˆ s2
Ti and ˆ s2
Ci are sample variances.
Thanks to the simulations, it is possible in practice to calculate the ‘actual’ vari-
ance of the estimates ˆ θ obtained with ˆ wi as well as the ‘declared’ variance of the
estimator. As at the end of 10000 runs we have ˆ θ1, ˆ θ2,..., ˆ θM with the respective vari-
ances ˆ V1, ˆ V2, ..., ˆ VM where M = 1,2,...,10000, we can calculate the real dispersion
of the estimates as
V real(ˆ θ) =
PM
j=1(ˆ θj − ˆ θ)2
(M − 1)
where ˆ θ =
M X
j=1
ˆ θj
M
(2.5)
and the expected variance E[ˆ V ] as
E[ˆ V ] =
M X
j=1
ˆ Vj
M
(2.6)
Finally, since when simulating data we have the privilege to know the correct values
for the treatment and control group variances, we can calculate the so called ‘opti-
mal’ variance, that is given by average of optimal variances calculated with the true
variances instead of with the sampled values, that is
V opt =
M X
j=1
Vj
M
where Vj =
1
Pk
i=1 wi
with wi = 1/σ2
i (2.7)
We give the results of the simulations if the ﬁxed-eﬀects model is the theoretically
correct one. In Table 2.1, the estimated actual percentage of CIs is given, that is the
proportion of intervals containing the true overall eﬀect θ out of 10000 runs. We can
observe, not surprisingly, that for small sample sizes the ﬁxed eﬀect model is rather
liberal and that for increasing sample sizes in the studies the estimated coverage prob-
ability get closer to the nominal signiﬁcance level (B¨ ockenhoﬀ & Hartung, 1998; Li
et al., 1994). The proportion of intervals which contains θ drops to 90% in the bal-
anced case nTi = nCi = 8 regardless of the number of trials considered. It is worth
to note that with increasing sample sizes one observes a stabilization of the actual
coverage probability. Moreover, from Table 2.1, it can be seen that the number of
16trials involved in the meta-analysis does not have a huge impact on the results. In
fact, turning to the coverage probabilities of the conﬁdence intervals (Figure 2.1), we
observe that the empirical coverage probabilities are below 95% for all k, even for a
large number of studies taken into account. The empirical coverage probabilities are
closer to the nominal values of 95% when a total number of 30 patients per study is
considered. The four graphs show in fact the same pattern; with n < 8 the empirical
coverage probability is far below the nominal value while with more than 15 patients
per arm the ﬁgures tend to get closer to the nominal value of 95%. Therefore, the
number of patients seems to be the most relevant aspect (at least in the case where
only trials with the same dimension and with the same number of patients per arm
are considered). The smaller the number of patients, the lower the coverage probability.
Moreover, Table 2.1 clearly shows that
V real(ˆ θ) ≥ V opt ≥ E[ˆ V ]
These relationships have a number of consequences. As we can only run 1 meta-
analysis, on average we tend to assert that the variance of the estimate obtained is
smaller that its ‘true’ optimal value. De facto, instead, the variability of such an esti-
mate is much larger than the true one. In practice, as the Table 2.1 shows, there is the
tendency to produce a variance estimate that is lower than that for the optimal esti-
mator. Nevertheless, the estimator is sub-optimal since its ‘actual’ variance V real(ˆ θ) is
higher than V opt. We claim that we are performing better than the optimal estimator
while, if we could run a number of meta-analyses, we would notice that the variability
of the estimate considered is larger than the ‘true’ one. Fixed-eﬀects meta-analyses pro-
duce an estimator whose true variance is higher than that produced by equal weighting
(the ‘correct one’) but which will appear to be lower. As a consequence, we tend to
overstate the signiﬁcance of the results.
17Table 2.1: The Results of Simulations for diﬀerent values of studies (k) under the
assumption of equal variances and equal study sizes
k = 10 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.052044 0.040000 0.031227 0.8603
8 0.029666 0.025000 0.021792 0.9008
10 0.022188 0.020000 0.018039 0.9193
15 0.014338 0.013333 0.012490 0.9309
20 0.010618 0.010000 0.009534 0.9376
30 0.006858 0.006667 0.006457 0.9420
50 0.004087 0.004000 0.003928 0.9468
k = 15 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.037335 0.026667 0.020577 0.8539
8 0.020113 0.016667 0.014495 0.9000
10 0.015149 0.013333 0.011969 0.9173
15 0.009435 0.008889 0.008297 0.9314
20 0.007051 0.006667 0.006343 0.9371
30 0.004589 0.004444 0.004302 0.9395
50 0.002692 0.002667 0.002618 0.9454
k = 20 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.028918 0.020000 0.015329 0.8470
8 0.014785 0.012500 0.010826 0.9063
10 0.011415 0.010000 0.008959 0.9154
15 0.007203 0.006667 0.006224 0.9334
20 0.005288 0.005000 0.004746 0.9352
30 0.003516 0.003333 0.003223 0.9376
50 0.002057 0.002000 0.001961 0.9447
k = 35 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.016244 0.011429 0.008684 0.8476
8 0.008535 0.007143 0.006152 0.9039
10 0.006467 0.005714 0.005098 0.9186
15 0.004160 0.003810 0.003546 0.9312
20 0.003104 0.002857 0.002710 0.9334
30 0.001997 0.001905 0.001841 0.9419
50 0.001190 0.001143 0.001120 0.9418
This Table shows the results of simulation for θ = 3 and diﬀerent values of n and k, given
S
2 = σ
2
Ti = σ
2
Ci = 1 for all i. This simulation scheme considers for each simulation k parallel group
clinical trials each of whom with the same number of patients per arm (n = nT = nC). Empirical
Statistics for E(ˆ V ) and V
real(ˆ θ) are based on 10000 simulation replicates as well as the Empirical
Coverage Probability.
18Figure 2.1: Estimated Coverage Probabilities for the Fixed-Eﬀects method under the
assumptions of Common Variances and Equal Number of Patients per Arm
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The ﬁgures show Estimated Coverage Probabilities of the Conﬁdence Intervals based on 10000
simulation replicates. Diﬀerent values of k –the number of trials – and n –the number of patients per
arm, with n = nC = nT– are considered: (a) k = 10, (b) k = 15, (c) k = 25, (d) k = 35.
192.6.2 Number of Patients per Arm not Equal
So far we have considered the case where the number of patients per each arm is equal.
We now take into account the cases where nT 6= nC. In particular, we consider the case
where on average all clinical trials have the same amount of patients per arm. This
implies that E(nT) = E(nC). Therefore, in order to consider clinical trial where each
arm has on average the same amount of patients, we sample the dimension of each arm
from a negative binomial distribution. The negative binomial distribution is a discrete
probability distribution,commonly parameterized by two real-valued parameters p and
r with 0 < p < 1 and r > 0. Under this parameterization, the probability mass function
of a random variable with a NegBin(r, p) distribution takes the following form:
f(k;r,p) =
Γ(r + k)
k!Γ(r)
pr(1 − p)k
for k = 1,2,3,... and where Γ is the Gamma Function. The NegBin(r, p) distribution is
the probability distribution of a certain number of failures (r) in a series of independent
and identically distributed Bernoulli trials given p as the probability of success (Piccolo,
2000). Speciﬁcally, this is the probability distribution of the number of failures before
the kth success in a Bernoulli process, with probability p of success on each trial.
Formulae for the expectation and the variance for the negative binomial distribution
are given by
E(X) =
r(1 − p)
p
V ar(X) =
r(1 − p)
p2
Hence, if we impose the average number of patients per arm (with at least 2 patients
per arm), we can obtain various negative binomial distributions each of which with
diverse variances. In our study, we decided to consider the cases where the variances of
the negative binomial distributions are equal to 5. Higher values of the variance were
not taken into account as this would have implied extremely high number of patients
per arm which are quite unrealistic. Given a variance equal to 5, the negative binomial
distribution whose mean is 5 assumes values ranging from 2 to 18. Similarly, as shown
in the following graphs, given a variance equal to 5 and an average value equal to 15,
the barplot of such a probability distribution has values varying from 2 to 37.
20Figure 2.2: Bar Plots of a Probability Distribution of a negative Binomial
Bar Plots of a Probability Distribution of a negative Binomial with diﬀerent expected values (5 and
15 respectively) and same variances in both cases equal to 5
We run 10000 meta-analyses assuming the ﬁxed-eﬀects model as the correct one.
Table 2.2 shows the proportion of intervals containing the true overall eﬀect θ as well
as the ‘real’, the ‘optimal’ and the ‘declared’ variances of the estimates.
Once again, despite the fact we are now considering the case where nT and nC are the
same only on average, we can observe (Figure 2.3) that the estimated coverage proba-
bility gets closer to the nominal level (i.e. 95 %) only when the sample sizes increases.
The proportion of intervals which does not contain the true θ rises to 20% when we
consider only 5 patients per arm on average. Interestingly, under the assumption of
common variance, the number of clinical trials taken into account does not seem to
have an important impact on the output. The empirical coverage probabilities assume
roughly the same values regardless of k, the number of clinical trials. Again, looking at
both Figure 2.3 and Table 2.2, we can observe that the coverage probability is closer
to the nominal level when, on average, there are more than 15 people per arm, regard-
less of the number of studies. In fact, if we have a look at the ratio between the real
dispersion of the estimates and the mean of the variances of these estimates we can
21observe that, as the number of the average patients per arm increases, the ratio itself
tends to be roughly the same for all the four scenarios considered (k = 10, 15, 20 and
35). What really matters is the average total number of patients per trial: the less the
average amount of patients the lower is the coverage probability.
Figure 2.3: Estimated Coverage Probabilities for the Fixed-Eﬀects method under the
assumptions of Common Variances and Diﬀerent Number of Patients per Arm
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The ﬁgures show Estimated Coverage Probabilities of the Conﬁdence Intervals based on 10000
simulation replicates. Diﬀerent values of k and n (where n = nC = nT only on average) are taken into
account: (a) k = 10, (b) k = 15, (c) k = 25, (d) k = 35.
22Considering the same average number of patients per arm entails that not neces-
sarily every single trial has got the same allocation per arm and the same total number
of patients. For instance, in a meta-analysis where each study has an average total
number of 20 people it is likely to have clinical trials with more or less than 20 people
allocated in a more or less extreme unbalanced way. This has 2 consequences. First,
under the assumption of common variance, the average total number of patients ap-
pears to be more important than the amount of every single clinical trial. Second, the
allocation per arm of these people does not seem to be signiﬁcant.
In the following paragraphs the irrelevance of both the allocation and the amount of
people per study is proven investigating the eﬀect of random variation in variances
on meta-analysis. In order to simplify the calculation, in a ﬁrst instance we will con-
sider only two clinical trials under the assumptions of (i) equal number of patients
per trial when proving the insigniﬁcancy of the allocation and of (ii) balanced alloca-
tion when verifying the importance of the average total amount of patients considered.
Subsequently, both the allocation and the total amount of patients will be taken into
consideration at the same time.
23Table 2.2: The Results of Simulations for diﬀerent values of studies (k) under the
assumption of equal variances and equal study sizes on average
n k V real(ˆ θ) V opt E[ˆ V ]
V real(ˆ θ)
E[ˆ V ]
Coverage
Probability
5 10 0.13624 0.05532 0.03594 3.79055 0.7345
15 0.11109 0.03660 0.02307 4.81575 0.7026
20 0.09523 0.02726 0.01674 5.68843 0.6808
35 0.08067 0.01545 0.00911 8.85376 0.6267
8 10 0.03897 0.03024 0.02572 1.515 0.8929
15 0.02753 0.02000 0.01692 1.627 0.8793
20 0.02031 0.01495 0.01264 1.607 0.8874
35 0.01256 0.00850 0.00714 1.759 0.8756
10 10 0.02570 0.02280 0.02039 1.260 0.9166
15 0.01738 0.01513 0.01345 1.292 0.9151
20 0.01278 0.01130 0.01003 1.274 0.9153
35 0.00763 0.00645 0.00571 1.335 0.9104
15 10 0.01536 0.01417 0.01327 1.158 0.9329
15 0.01005 0.00941 0.00878 1.145 0.9315
20 0.00752 0.00707 0.00658 1.142 0.9317
35 0.00444 0.00403 0.00375 1.185 0.9268
20 10 0.01059 0.01034 0.00986 1.074 0.9413
15 0.00748 0.00690 0.00655 1.141 0.9280
20 0.00545 0.00517 0.00491 1.111 0.9351
35 0.00307 0.00295 0.00280 1.095 0.9395
30 10 0.00702 0.00680 0.00659 1.064 0.9423
15 0.00460 0.00453 0.00438 1.049 0.9430
20 0.00351 0.00339 0.00328 1.070 0.9432
35 0.00200 0.00194 0.00187 1.065 0.9425
50 10 0.00407 0.00406 0.00398 1.021 0.9484
15 0.00271 0.00271 0.00266 1.021 0.9473
20 0.00206 0.00203 0.00199 1.038 0.9468
35 0.00117 0.00116 0.00114 1.030 0.9479
This Table shows the results of simulation for θ = 3 and diﬀerent values of n and k, given S
2 = 1. This
simulation scheme considers for each simulation k parallel group clinical trials each of whom with the
same number of patients per arm on average(E(n) = E(nT) = E(nC)). Empirical Statistics for E(ˆ V )
and V
real(ˆ θ) are based on 10000 simulation replicates as well as the Empirical Coverage Probability.
242.7 Eﬀect of Allocation of Patients per Arm on Meta-
Analysis. 2 trials
We consider two clinical trials, each of which with the same total number of patients
(N = N1 = N2). Moreover, we suppose that the variances are equal to
σ2
1 = var(Y1) =

1
αN
+
1
(1 − α)N

S2
1 =

1
α(1 − α)N

S2
1 = γS2
1
σ2
2 = var(Y2) =

1
βN
+
1
(1 − β)N

S2
2 =

1
β(1 − β)N

S2
2 = δS2
2
where α and β represent the proportion of patients allocated to each arm of the trial,
N is the total number of patient per clinical trial and S2
1 = S2
2 = 1. The optimal weight
for trial 1 would be equal to
w
opt
1 =
1
σ2
1
1
σ2
1
+ 1
σ2
2
=
1
γS2
1
1
γS2
1
+ 1
δS2
2
=
1
γ
γ+δ
γδ
=
δ
γ + δ
given S2
1 = S2
2 = 1
while the empirical weight for trial number 1 would be
ˆ w
emp
1 =
1 ￿
1
αN + 1
(1−α)N
￿
ˆ S2
1
1 ￿
1
αN + 1
(1−α)N
￿
ˆ S2
1
+ 1 ￿
1
βN + 1
(1−β)N
￿
ˆ S2
2
=
1
γ ˆ S2
1
1
γ ˆ S2
1
+ 1
δ ˆ S2
2
=
=
1
γ ˆ S2
1
∗
γ ˆ S2
1δ ˆ S2
2
[δ ˆ S2
2 + γ ˆ S2
1]
=
δ ˆ S2
2
[δ ˆ S2
2 + γ ˆ S2
1]
=
δ
δ + γr
given
ˆ S2
1
ˆ S2
2
= r
Therefore the optimal variance of the estimator will be equal to
V opt = var(θopt) =

δS2
2
δS2
2 + γS2
1
2
γS2
1 +

δS2
2
δS2
2 + γS2
1
2
δS2
2 =
=
1
[γ + δ]2
 
γδ2 + γ2δ

= γδ
[γ + δ]
[γ + δ]2 =
γδ
γ + δ
=
1
1
γ + 1
δ
Similarly, the empirical overall variance will become.
ˆ V emp = var(θemp) =
"
δ ˆ S2
2
γ ˆ S2
1 + δ ˆ S2
2
#2
γS2
1 +
"
γ ˆ S2
1
γ ˆ S2
1 + δ ˆ S2
2
#2
δS2
2 =
=

δ
δ + γr
2
γ +

γr
δ + γr
2
δ =
1
[δ + γr]2
 
δ2γ + γ2r2δ

=
= δγ
(δ + γr2)
(δ + γr)2
25And the ratio of this to the optimal will be
Υ =
var(θemp)
var(θopt)
=
δγ
(δ+γr2)
(δ+γr)2
γδ
γ+δ
=
(δ + γr2)
(δ + γr)2(δ + γ) (2.8)
where γ and δ depend on the proportion of patients per arm and where r can assume
values theoretically in the range (0,∞). Actually, such a proportion does not depend
on the total number of patients per clinical trials if we assume that both trials have
the same dimension. In fact,
(δ + γr2)
(δ + γr)2(δ + γ) =

1
α(1−α)N + r2
β(1−β)N

1
α(1−α)N + 1
β(1−β)N


1
α(1−α)N + r
β(1−β)N
2 =
=
1
N2

1
α(1−α) + r2
β(1−β)

1
α(1−α) + 1
β(1−β)

1
N2

1
α(1−α) + r
β(1−β)
2 =
=

1
α(1−α) + r2
β(1−β)

1
α(1−α) + 1
β(1−β)


1
α(1−α) + r
β(1−β)
2
This means that the ratio Υ only depends on α, β and on r. In general, to give
an idea of the behaviour of the ratio we can plot it with diﬀerent values of α and β.
The following graphs (Figure 2.4) give us a rough idea in the cases where α assumes
the values (0.1, 0.2, 0.3 and 0.5) while β ranges from 0.1 to 0.9.
26Figure 2.4: Random Variation in Variances on a Meta-Analysis with 2 trials. Eﬀect of
Allocation of patients per arm.
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These Figures show the variance behaviour of the ratio of the real overall variance to the optimal
value as r increases and under the assumption of 2 studies each of which with the same total number
of patients N. The 5 lines represent diﬀerent values of β (– = 0.9, 0.1, – = 0.8, 0.2, – = 0.7, 0.3, – =
0.6, 0.4, – = 0.5 ) while α is set equal to 0.1 (a), 0.2 (b), 0.3 (c) and 0.5(d).
27To have a better idea we can even plot them on a logarithmic base (Figure 2.5).
Figure 2.5: Random Variation in Variances on a Meta-Analysis with 2 trials. Eﬀect of
Allocation of patients per arm - Logarithm Scale.
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These Figures show the variance behaviour of the ratio of the real overall variance to the optimal
value as r increases and under the assumption of 2 studies each of which with the same total number
of patients N. Again, the 5 lines represent diﬀerent values of β (... = 0.9, 0.1, ... = 0.8, 0.2, ... =
0.7, 0.3, ... = 0.6, 0.4, ... = 0.5 ) while α is set equal to 0.1 (a), 0.2 (b), 0.3 (c) and 0.5(d). The
logarithm scale is considered.
28As r ranges from simulation to simulation, we can see the average behaviour of the
ratio of the empirical and the optimal variances Υ calculating the mean. As we have
assumed an equal total number of patients per each clinical trial, i.e. N1 = N2 = N, it
follows that r =
ˆ S2
1
ˆ S2
2
∼ F(N−2),(N−2), where F is the F distribution with both degrees
of freedom equal to N-2. Given α, β and N, the expected value of the ratio is equal to
E(α,β,N) =
Z ∞
0
Υ(α,β,r) ∗ dF(r,N−2 ,N−2 )dr
where
dF(r,ν1 ,ν2 ) =
1
Beta(ν1
2 , ν2
2 )

ν1
ν2
 ν1
2 r
ν1
2 −1

1 + ν1r
ν2
 ν1+ν2
2
given F(ν1,ν2) with ν1 and ν2 representing the degrees of freedom. The following tables
show the expected value of the ratio between the variance of the optimal and empirical
estimator. Each table shows the expected values for the main possible combination of
the proportion of total number of patients per arm, i.e. α and β.
Table 2.3: Expected values of the ratio of the empirical overall variance to the optimal.
Eﬀect of Allocation for N=30
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
0.1 1.0345 1.0325 1.0304 1.0291 1.0287 1.0291 1.0304 1.0325 1.0345
0.2 1.0325 1.0345 1.034 1.0335 1.0333 1.0335 1.034 1.0345 1.0325
0.3 1.0304 1.034 1.0345 1.0344 1.0343 1.0344 1.0345 1.034 1.0304
0.4 1.0291 1.0335 1.0344 1.0345 1.0345 1.0345 1.0344 1.0335 1.0291
0.5 1.0287 1.0333 1.0343 1.0345 1.0345 1.0345 1.0343 1.0333 1.0287
0.6 1.0291 1.0335 1.0344 1.0345 1.0345 1.0345 1.0344 1.0335 1.0291
0.7 1.0304 1.034 1.0345 1.0344 1.0343 1.0344 1.0345 1.034 1.0304
0.8 1.0325 1.0345 1.034 1.0335 1.0333 1.0335 1.034 1.0345 1.0325
0.9 1.0345 1.0325 1.0304 1.0291 1.0287 1.0291 1.0304 1.0325 1.0345
This Table shows the expected means of the ratio of the real overall variance to the optimal value
when diﬀerent allocations per arm per study are considered. The rows represent the allocation in
study 1 (i.e. α), while the columns represent possible values of β, the allocation in the study 2. The
total number of patients in both studies (N1, N2) is set to 30.
29Table 2.4: Expected values of the ratio of the empirical overall variance to the optimal.
Eﬀect of Allocation for N=80
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
0.1 1.0127 1.0118 1.0108 1.0103 1.0101 1.0103 1.0108 1.0118 1.0127
0.2 1.0118 1.0127 1.0125 1.0122 1.0121 1.0122 1.0125 1.0127 1.0118
0.3 1.0108 1.0125 1.0127 1.0126 1.0126 1.0126 1.0127 1.0125 1.0108
0.4 1.0103 1.0122 1.0126 1.0127 1.0127 1.0127 1.0126 1.0122 1.0103
0.5 1.0101 1.0121 1.0126 1.0127 1.0127 1.0127 1.0126 1.0121 1.0101
0.6 1.0103 1.0122 1.0126 1.0127 1.0127 1.0127 1.0126 1.0122 1.0103
0.7 1.0108 1.0125 1.0127 1.0126 1.0126 1.0126 1.0127 1.0125 1.0108
0.8 1.0118 1.0127 1.0125 1.0122 1.0121 1.0122 1.0125 1.0127 1.0118
0.9 1.0127 1.0118 1.0108 1.0103 1.0101 1.0103 1.0108 1.0118 1.0127
This Table shows the expected means of the ratio of the real overall variance to the optimal value
when diﬀerent allocations per arm per study are considered. The rows represent the allocation in
study 1 (i.e. α), while the columns represent possible values of β, the allocation in the study 2. The
total number of patients in both studies (N1, N2) is set to 80.
Regardless of the combination of the values α and β, given N, it appears that our
function Υ tends to assume roughly the same values; this implies that the allocation per
arm does not aﬀect the analysis. What really matters is the total number of patients
per clinical trial and not the way patients are allocated in each arm. In other words,
the crucial factor is the degrees of freedom available for estimating the within trial
variance. In fact, as the total number per clinical trial increases, the expected values
tend to be closer to 1 (cf. Tables 2.3 and 2.4, with N=30 and N=80 respectively).
302.8 Eﬀect of Number of patients per Trial on meta-analysis.
2 Trials Example
In this case we consider two clinical trials with a given total number of patients equal
to 2N. However, in this case, the number of patients per trial will vary. This means
that we can consider 2n1 patients in trial 1 and 2n2 in trial 2, where 2n1 + 2n2 = 2N.
As the allocation per arm does not really aﬀect the meta-analysis in the case where
the variance is supposed to be equal in both clinical trials, we consider a balanced
allocation (i.e. n1 patients per arm in the clinical trial 1 and n2 patients per arm in
the clinical trial 2) in order to simplify the calculation. Moreover, we suppose that the
variances are equal to
σ2
1 = var(Y1) =

1
n1
+
1
n1

S2
1 =

2
n1

S2
1
σ2
2 = var(Y2) =

1
n2
+
1
n2

S2
2 =

2
n2

S2
2
where S2
1 = S2
2 = 1.
In this case, the optimal scheme will be to weight the trials according to the numbers
of patients, that is to use weights equal to n1/N and to n2/N respectively. In fact, if
we consider only the trial 1, we have that the optimal weight is equal to
wopt =
n1
2S2
1
n1
2S2
2
+ n2
2S2
2
=
n1
2S2
1
n1S2
2+n2S2
1
2S2
1S2
2
=
n1
n1 + n2
=
n1
N
given that in the optimal scenario S2
1 and S2
2 are known and equal to 1 and where n1+
n2 = N. Given the optimal weights, the optimal estimator will have an overall variance
equal to 2/N. In fact, recalling that when we perform meta-analysis, we consider the
estimator
θ =
Pk
i=1 wiYi
Pk
i=1 wi
=
k X
i=1
qiYi where qi =
wi
Pk
i=1 wi
with wi = 1/σ2
i
and that the overall variance of such estimator, V, is usually estimated by
V = var(θ) =
1
Pk
i=1 wi
with wi = σ2
i
the optimal overall variance becomes
V opt =
n1
N
2 2
n1
+
n2
N
2 2
n2
=
2(n1 + n2)
N2 =
2
N
However, the estimated weights as well as the estimated overall variance should take
into account the fact that the variance is unknown. De facto, we could impose and
presume to know the variance of each single trial when it comes to calculate the overall
31variance of the estimator. Nonetheless, the weights will inevitably depend on the
observed variances in each trial. Therefore, for trial 1 -for instance - the weight will be
equal to
wemp =
n1
2ˆ S2
1
n1
2ˆ S2
2
+ n2
2ˆ S2
2
=
n1
2ˆ S2
1
n1 ˆ S2
2+n2 ˆ S2
1
2ˆ S2
1 ˆ S2
2
=
n1
2ˆ S2
1
 
2ˆ S2
1 ˆ S2
2
n1 ˆ S2
2 + n2 ˆ S2
1
!
=
=
n1 ˆ S2
2
n1 ˆ S2
2 + n2 ˆ S2
1
=
n1
n1 + n2r
given r equal to the observed ratio of within trial variances for the trial 1 compared
to the trial 2 (i.e. r = ˆ S2
1/ˆ S2
2 ). As a consequence, the overall observed variance, in
the case where we take into account the observed variances only when calculating the
weights of the trials, becomes
ˆ V emp =

n1
n1 + n2r
2 2
n1
+

n2r
n1 + n2r
2 2
n2
= 2
(n1 + n2r2)
(n1 + n2r)2
The ratio of this variance to the optimal one will be equal
Ψ =
var(θemp)
var(θopt)
=
2
(n1+n2r2)
(n1+n2r)2
2
N
=
(n1 + n2r2)
(n1 + n2r)2(n1 + n2) (2.9)
where n1 and n2 represent the total number of patients per arm in each clinical trial
and r (the ratio of the observed variances) assumes theoretically values ∈ (0,∞). This
means that the ratio depends only on the average total number of patients and on r.
In general, to give an idea of the behaviour of the ratio we can plot it with diﬀerent
values of n1 and n2. The following graphs (Figure 2.6) give us a rough idea in the cases
where N assumes the value 50 with at least 5 people per clinical trial on a Normal (a)
and a Logarithmic scale (b).
32Figure 2.6: Random Variation in Variances on a Meta-analysis with 2 trials. Eﬀect of
Number of patients per trial
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(b) Variance Ratio
These ﬁgures show the variance inﬂation of the ratio of the real overall variance to the optimal overall
variance (Ψ) as r –the observed ratio of within trial variances for trial 1 compared to trial 2–
increases. Each line represents a possible combination of 2n1 and 2n2 under the constraint of a total
number of patients 2n1 + 2n2 = 50 and under the assumption of a balanced allocation in each trial.
Both the Normal Scale (a) and the Logarithmic Scale (b) are considered
33As r ranges from simulation to simulation, we can see the average behaviour of
the ratio of the empirical and the optimal variances calculating the mean. As we have
assumed an average total number of patients equal to 2N, it follows that r =
ˆ S2
1
ˆ S2
2
∼
F(2n1−2),(2N−2n1−2), where F is the F distribution with degrees of freedom equal to
2n1 − 2 and to 2n2 − 2. The expected value of the ratio, given N, is then equal to
E(n1,n2) =
Z ∞
0
Ψ(n1,n2,r) ∗ dF(r,2n1−2 ,2n2−2 )dr
where
dF(r,ν1 ,ν2 ) =
1
Beta(ν1
2 , ν2
2 )

ν1
ν2
 ν1
2 r
ν1
2 −1

1 + ν1r
ν2
 ν1+ν2
2
given F(ν1,ν2) with ν1 and ν2 representing the degrees of freedom.
As a consequence, if we give the total number of patients 2N we can compute the
average of the ratio between the observed and the optimal overall variances for the
estimator for all possible combinations of n1 and n2. Imposing that each single trial
has at least 5 patients in total, we can see that the the ratio has on average values close
to 1. Moreover, as the average total number of patients increases, the ﬁgures tend to
be closer to 1 (i.e. the overall empirical and optimal variances of the estimator tend to
be the same).
Figure 2.7: Expected Variance Inﬂation for N=30 on a Meta-Analysis with 2 trials
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(a) Patients in Trial 1
This ﬁgure shows the Expected Variance Inﬂation on a Meta-Analysis with only 2 trials for diﬀerent
number of patients (perfectly balanced among arms) in each of the 2 studies; the x axis represents the
patients allocated in trial 1, given a total of 30 patients in the 2 trials
34Figure 2.8: Expected Variance Inﬂation for N=60 on a Meta-Analysis with 2 trials
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(b) Patients in Trial 1
This ﬁgure shows the Expected Variance Inﬂation on a Meta-Analysis with only 2 trials for diﬀerent
numbers of patients (perfectly balanced in the 2 arms) in 2 studies. The x axis represents the patients
allocated in trial 1, given that a total number of 60 patients in the 2 trials is considered
2.9 Eﬀect of Patients and Allocation per Arm. 2 Trials
Example
Let the variances of responses for trial 1 and 2 be both equal to 1. However, in this
case, both the number of patients per trial and the allocation per arm in each trial will
vary. Suppose n1 patients in trial 1 and n2 in trial two for a total number of N patients.
Moreover, let’s denote the allocation of patients in one arm as α and β for trial 1 and
2 respectively. Hence,
σ2
1 = var(Y1) =

1
αn1
+
1
(1 − α)n1

S2
1 =

1
α(1 − α)n1

S2
1
σ2
2 = var(Y2) =

1
βn2
+
1
(1 − β)n2

S2
2 =

1
β(1 − β)n2

S2
2
The optimal scheme to weight the trials will therefore depend on both the allocation
and the number of people involved in each study. In fact, the optimal weight is equal
to
w
opt
1 =
1
var(Y1)
1
var(Y1) + 1
var(Y2)
S2
1=S2
2=1
=
α(1 − α)n1
α(1 − α)n1 + β(1 − β)n2
These weights yields an estimator with an optimal overall variance given by
V opt = var(θ) = (w
opt
1 )2var(Y1) + (w
opt
2 )2var(Y2) =
=

α(1 − α)n1
α(1 − α)n1 + β(1 − β)n2
2 S2
1
α(1 − α)n1
+

β(1 − β)n2
α(1 − α)n1 + β(1 − β)n2
2 S2
2
β(1 − β)n2
=
=
1
α(1 − α)n1 + β(1 − β)n2
given S2
1 = S2
2 = 1
35Now, let us consider the observed variances. The empirical weight for trial 1 becomes
w
emp
1 =
α(1−α)n1
ˆ S2
1
α(1−α)n1
ˆ S2
1
+
β(1−β)n2
ˆ S2
2
=
α(1 − α)n1
ˆ S2
1
×
ˆ S2
1 ˆ S2
2
ˆ S2
2α(1 − α)n1 + ˆ S2
1β(1 − β)n2
=
=
α(1 − α)n1
α(1 − α)n1 + β(1 − β)n2r
given ˆ S2
1/ˆ S2
2 = r
and the overall empirical variance of the estimator becomes
ˆ V emp = var(ˆ θ) =

α(1 − α)n1
α(1 − α)n1 + β(1 − β)n2r
2 1
α(1 − α)n1
+

β(1 − β)n2r
α(1 − α)n1 + β(1 − β)n2r
2 1
β(1 − β)n2
=
=
α(1 − α)n1 + β(1 − β)n2r2
[α(1 − α)n1 + β(1 − β)n2r]
2
The ratio of this variance to the optimal one will be equal to
Ξ =
var(ˆ θ)
var(θ)
=
α(1 − α)n1 + β(1 − β)n2r2
[α(1 − α)n1 + β(1 − β)n2r]
2 × [α(1 − α)n1 + β(1 − β)n2]
Ξ depends on α, β, n1 and n2. Just to give an idea of the behaviour of Ξ when r ranges
from 0 to 10, we can plot this function for diﬀerent values of n1 and n2, given α and
allowing for diﬀerent values of β or viceversa. The following four plots (Figure 2.9), for
example, show the behaviour of Ξ for all the possible combinations of n1 and n2 given
N=30 and for four diﬀerent values of α (0.1, 0.3, 0.6, 0.8) given β equal to 0.3 in all
four cases.
36Figure 2.9: Random Variation in Variances on a Meta-analysis with 2 trials. Eﬀect of
both Allocation and Number of patients per trial
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(d) Variance Ratio
These 4 ﬁgures show the variance inﬂation of the ratio of the real overall variance to the optimal
overall variance as r –the observed ratio of within trial variances for trial 1 compared to trial 2–
increases. Each line represents the variance behaviour for a possible combination of n1 and n2, given
n1 + n2 = 30. Unbalanced allocation is assumed: the allocation per arm in the trial 2 (β) is ﬁxed and
set to 0.3 while the allocation per arm in trial 1 (α) changes for every ﬁgure ( 0.1, 0.3, 0.6 and 0.8 for
ﬁgures from (a) to (d) respectively).
37Similarly, Figure 2.10 shows the same situation in the case where α is ﬁxed equal
to 0.5 while β varies and assumes the values 0.1, 0.3, 0.6 and 0.8.
Figure 2.10: Random Variation in Variances on a Meta-analysis with 2 trials. Eﬀect of
both Allocation and Number of patients per trial
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(c) Variance Ratio
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These 4 ﬁgures show the variance inﬂation of the ratio of the real overall variance to the optimal
overall variance as the observed ratio of within trial variances for trial 1 compared to trial 2 increases.
Each line represents the variance behaviour for each possible combination of n1 and n2, given
n1 + n2 = 30. While the allocation per arm in the trial 1 is balanced (α = 0.5), β changes for every
ﬁgure (0.1, 0.3, 0.6 and 0.8 for ﬁgures from (a) to (d) respectively).
In order to have a better idea of the average behaviour of the function, we can
calculate the expected value of Ξ under the assumption that r ∼ Fn1−2,n2−2. Results
are given in Table 2.5 for N=30, β ﬁxed and equal to 0.8 (in Table 2.5.a), 0.4 (in Table
2.5.b) and 0.1 (in Table 2.5.c) while α assumes values ranging from 0.1 to 0.9. Each
row represents diﬀerent values of α (from 0.1 to 0.9) while each column represents the
number of patients in trial 1 given a total number of patients of 30 patients and under
the assumption that there are at least 5 patients in each study (i.e., if N=30, n1 ranges
from 5 to 25).
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40All these matrices may not be easy to interpret, especially when N increases. A
3D visualization may better show the pattern of the calculated expected values of the
ratio of the variances. Once again, we ﬁx the value β for each single 3D representation
( 0.8, 0.6, 0.3 and 0.1) and we set N, the combined number of subjects in the 2 trials,
equal to 40. The x axis represents the number of patients in trial 1 (and consequently
we can determine the patients in the second trial) while the y axis shows the diﬀerent
values of α, i.e. the allocation per arm in trial 1 (while patients in trials 2 will always
have the same allocation β). The 4 graphs have roughly the same pattern and the same
values for every possible combination of the four variables taken into account. It can
be seen from the three-dimensional plots that the distribution of the ratio between the
empirical and the optimal variances is, as expected, symmetric (as we only considered
2 trials). Patterns and values change slightly with diﬀerent values of β. The ratio Ξ
tends to assume values distant from 1 when we consider the extreme cases with only
few patients allocated in one trial, regardless of the allocation per arm. In all other
cases, diﬀerences are, on average, undetectable; the ratio calculations change by only
0.03 in the region covering most of the cases and combinations (from 10 to 30 subjects
in trial 1). Therefore, the distribution of the combined number of patients (i.e. the
total subjects in each single study) as well as the allocation per arm per study does not
have much inﬂuence on ˆ V .
Nonetheless, if we observe the proﬁles of the expected values it can be seen that the
minimum of the calculated ratio is reached when both the trials have the same number
of patients as well as when the allocation is balanced (both arm in the trial have the
same number of patients). Under these circumstances, the ratio is closer to 1; this means
that, on average, the overall variance of the estimator is almost perfectly estimated.
Just so almost, though. The expected ratio never reaches the value 1. Therefore,
the overall variance of the estimator is on average higher than the optimal one. As
proven via simulations, the ‘real’ dispersion of the estimator is de facto higher than
that of the optimal one even though we tend to declare that the estimate has a smaller
overall variance. On the average, the estimate of the variance of the overall eﬀect by
using the variance weighted method in meta-analysis underestimates the true pooled
variance (i.e. the signiﬁcance level is overestimated). There is a tendency to produce
variance estimate lower than the optimal true one even though the ‘real’ variance of
the estimator used is higher. The estimate of the overall variance should then consider
both the eﬀect of the sample size and the variation of sample variances in order to
produce more reliable ﬁgures.
41Figure 2.11: 3-D Visualisation of the Expected Variance Inﬂation for N=40 on a Meta-
Analysis with 2 trials
These 4 ﬁgures show the Expected variance inﬂation of the ratio of the real overall variance to the
optimal overall variance for diﬀerent values of patients and allocation in both trials 1 and 2. Each
ﬁgure represents the expected values for a ﬁxed value of β while n1 and α varies. In particular, α
ranges from 0.1 to 0.9 while the number of patients in trial 1 ranges from 5 to 35 given a total
number of 40 patients among the 2 studies. β for each single 3D representation is set to (a) 0.8, (b)
0.6, (c) 0.3 and (d) 0.1
2.10 Precision of the overall estimator: a recap
Even though “the simulated data sets should have some resemblance to reality for the
results to be generalizable to real situations and have any credibility” (Burton et al.,
2006, pg. 4283), so far we have investigated the behaviour of the precision of the overall
estimator (paying attention particularly to the individual within-study variances) under
the assumption of homoscedasticity where all studies have exactly the same nominal
value of the internal variance (i.e. S2 = σ2
Ti = σ2
Ci for all i). We simulated diﬀerent
scenarios in order to evaluate both the importance of the total patients present in each
study and the signiﬁcance of the allocation of patients in each arm of each study. At
least under the assumption of common variance, the average number of patients per
trial is more important than the total number of each single study. Moreover, the
allocation of patients per arm does not seem to be decisive for the estimated overall
42variance of the estimator. Nonetheless, having a perfect balanced allocation as well as
having roughly the same amount of patients per study yield better results. Further-
more, true to form, the higher the average number of patients considered in each arm,
the closer the estimator is to the optimal one, i.e. the fewer the number of patients
the less precise the estimates of S2
i ’s are and the greater the impact is on the results.
These conclusions were obtained not only via simulations but they even were math-
ematically demonstrated, at least for the case including only two studies. Moreover,
coverage probabilities (obtained by simulating 10000 meta-analyses and considering
diﬀerent patterns and scenarios) show that wrongly reported values of the variance
can badly underestimate the overall variance of the estimator. This happens especially
when trials with few patients are taken into consideration. Unsurprisingly, when we
consider a number of small trials we generally overestimate precision and this leads to
unreliable results, as we tend to overstate the signiﬁcance of the results. In particular
when the meta-analysis is dominated by very small studies, caution needs to be ex-
ercised. In fact, “the estimated weight ˆ wi has expectation E( ˆ wi) = (ni)wi/(ni − 3),
where ni = nTinCi/(nTi +nCi) rather than E( ˆ wi) = wi. This bias in the estimation of
the weights not only aﬀects the power of the test, but also the estimate of the variance
of the overall eﬀect and the estimate of the between-study variance τ. Hence, when
numbers are very small, results should be interpreted cautiously” (Hardy & Thompson,
1998, pg. 853).
“The bias of the estimate of the variance of the overall eﬀect synthesised from in-
dividual studies by using the variance weighted method is proven to be negative” (Li
et al., 1994, pg. 1063). Furthermore, such an estimate of the variance of the estimator
is also too sensitive to the minimum of the estimates of the variances in the k studies.
“If the ˆ σ2
min happens to be wrongly reported to have a very small value, the inﬂuence
on var(ˆ θ) by this estimate would be over-emphasized” (Li et al., 1994, pg. 1065) and
ˆ V would badly underestimate the true overall variance.
As we have shown via calculation (for two trials, without loss of generality) and sim-
ulations, on average, the estimate of the overall variance (ˆ V ) underestimates the true
value. “If there is an outlier or measurement error which gives an extremely small
sample variance, the pooled variance will badly underestimate the true variance by the
ordinary method and the weight of this individual sample for the combined mean will
be too high” (Li et al., 1994, pg. 1083). “The ordinary method is too sensitive to the
variation of the sample variances and biased if the sample size is not large” (Li et al.,
1994, pg. 1082). As a consequence, an adjusted method that considers both the eﬀect
of small sample and the variation of the variances and which is not too sensitive to any
individual result is necessary.
43Especially when we consider small trials, are there better estimations of the variances?
As the estimation of the variance and the number of patients are highly correlated (the
larger the sample size the closer the estimate of the the variance is to the real value), are
there methods capable to shrink the variances and account for their random variation
in order to have an estimator which does not depend so badly on the sizes of clinical
trials?
How can we produce less biased estimate? Can we adjust the weight method in order
to consider the eﬀect of small sample sizes? Is there a robust weight method with
regard to the variation of the sample variances and sample sizes not too sensitive to
any individual result?
44Chapter 3
Shrinkage Estimators and a more
Realistic Scenario
3.1 Acting in a more Realistic Scenario
So far we have considered the assumption of common variances, however, such an
assumption may be unrealistic. Therefore, in this chapter we consider the case where
the population variances of the observation at the patient level diﬀer from study to
study, by analysing two diﬀerent simulation schemes. The ﬁrst one will arbitrarily
impose the values of the variances, and the second one will draw the values from a
Gamma distribution. In both designs we will consider a perfect balance because in
most of the trials the sample sizes ni for the control and the treatment groups are
generally similar. Nonetheless, instead of considering k studies all of which have the
same size, we will impose the sample size to be equal only on average.
First Simulation Design
Following the example of the simulation study conducted by Knapp et al. (2006), the
ﬁrst simulation study considers equal allocation (i.e. ni = nCi = nTi) and diﬀerent
values for the S2
i (where S2
i = σ2
Ti = σ2
Ci). As in the paper by Knapp et al., we
“arbitrarily choose the base value of S2
i to be equal to 100 and deviations from this value
for a few of the S2
i are made to reﬂect patterns of imbalance possible in application.”
The ﬁrst pattern has roughly half of the S2
i = 100 while the second one - the most
imbalanced - has roughly 80-90% of the S2
i = 100. When S2
i is not equal to 100, the
value chosen is S2
i = 10. As mentioned above, the sample sizes, varying from 5 to 50
people per arm, are balanced. This means that for S2
i = 100 the within-trial variability
ranges (on average) from 40 to 4 as n increases from 5 to 50, respectively.
The aim of such a simulation design is to evaluate how important the eﬀect on the overall
45variance is when a few estimates from a few clinical trials carry a disproportionate
amount of weight, that is when a few of the within trial variances σ2
i = var(Yi) =
(1/nCi + 1/nTi)S2
i are much smaller than the others.
Second Simulation Design
In this case, as suggested by Tong and Wang (2007), S2
i ’s for i=1,...,k, are simulated
from a Gamma distribution with shape parameter γ and scale parameter β. β is set at
1 ”because it has little impact on the comparative performance” (Tong & Wang, 2007,
pg. 116). In order to evaluate the performance of the estimator under diﬀerent levels of
variance heterogeneity, three diﬀerent shape parameters are considered, γ = 0.25, 1 and
4, which correspond to three diﬀerent coeﬃcients of variation (CV =
p
γβ2/(γβ) =
√
γ/γ) at levels 2, 1, and 0.5 respectively. These three diﬀerent settings represent
commonly encountered cases; for example, γ=0.25 corresponds to the case with diﬀerent
variances across studies whereas γ = 4 corresponds to highly similar values of S2
i .
3.2 Simulations with uncommon variances
We design the simulation study to roughly follow the characteristic of a more realistic
meta-analysis. We consider two diﬀerent schemes for the variance of the observations
at the patients level and for each pattern we discuss the meta-analytical combination
of the results of k clinical trials, where k = 10, 15, 20, 35. The true overall eﬀect θ is
set at 3. The error probability α is restricted to the common value 0.05 in constructing
the approximate 100(1 − α) conﬁdence interval for θ.
As in the previous simulation designs, we consider a meta-analysis of k similar but inde-
pendent studies. The observations consist of two sets of independent random variables
XTi1,XTi2,...XTinTi and XCi1,XCi2, ... XCinCi for i=1, 2, ..., k from the treatment
and the control groups, respectively. These two sets of variables have independent
normal distributions with diﬀerent means and equal variances, S2
i , as follows
XTi1,XTi2,..., XTinTi ∼ N(µTi,σ2
Ti)
XCi1,XCi2,...,XCinCi ∼ N(µCi,σ2
Ci)
for i = 1,...,k where σ2
Ti = σ2
Ci = S2
i
The parameter of interest, denoted by θ, is the overall mean diﬀerence. The study
speciﬁc mean diﬀerence is deﬁned as Yi = (µTi − µCi) and is estimated by Yi = XTi −
XCi, where XTi =
PnTi
j=1 XTij/nTi and XCi =
PnCi
j=1 XCij/nCi. We assume that Yi is
such that E(Yi) = θ and that the variance of the diﬀerence between two independent
means based on nTi and nCi observations respectively is equal to var(Yi) = σ2
i =
σ2
Ti/nTi + σ2
Ci/nCi = S2
i (1/nTi + 1/nCi) given that the two groups in the treatment
and control arms have the same variance. For moderately large study sizes, each Yi
46should be asymptotically normally distributed. Thus,
Y i ∼ N(θ,σ2
i ) for i = 1,2,...,k
where σ2
i varies from study to study accordingly to the values assumed by S2
i . Once S2
i
is set for each study, the study speciﬁc mean diﬀerence is computed. For each single
study, we use equal sample sizes (ni = nCi = nTi) for the control and the treatment
groups since these values tend to be similar in parallel trials; ni’s are sampled from
a Negative Binomial Distribution in order for the k clinical trials to have on average
the same amount of patients per arm and per study, where E(ni)’s are equal to 5, 8,
10, 15, 20, 30 and 50. The simulations are implemented using the software package R,
with each simulation generating nTi and nCi observations from normal distributions
with mean µTi and µCi = µTi+θ respectively and variance S2
i . This procedure is repli-
cated k times for each of the 10000 independent simulations run. At each replicate, the
study speciﬁc mean diﬀerences (Yi) as well as their variances ˆ σ2
i are computed. These
estimates allow us to obtain the estimated weights ˆ wi for each study and therefore
to calculate the overall eﬀect estimate ˆ θ and its overall variance estimate ˆ V for each
replicate.
As done in the previous simulations, we summarise the estimates once all simulations
have been performed. In particular, we report the ‘declared’ estimate of the overall
variance as well as the ‘optimal’ and the ‘real’ variance of the point estimates (see
equations 2.5 - 2.7). Furthermore, in order to evaluate the performance and the preci-
sion of the results obtained from the diﬀerent scenarios and approaches being studied,
the coverage of the conﬁdence intervals is shown. Again, a possible criterion for ac-
ceptability of the coverage is that the coverage should not fall outside of approximately
two SEs of the nominal coverage probability.
In general our goal is to obtain not only an empirical estimated coverage probability
corresponding to the nominal value but also, and more importantly, both the ‘declared’
precision and the ‘actual’ dispersion of the overall variance of the estimator close to the
theoretical ‘optimal’ one.
3.3 The simulation results
We give the results if no heterogeneity in the treatment eﬀect is present, that is assum-
ing the ﬁxed-eﬀects model is the theoretically correct one. The ‘actual’, ‘optimal’ and
‘declared’ variances are given in Tables 3.1 - 3.5 for the 5 diﬀerent scenarios (i.e. diﬀer-
ent values of k and S2
i ). Also, the empirical coverage probabilities of the approximate
95% conﬁdence intervals based on the ‘empirical’ weights and variances are shown in
Figs 3.1 - 3.2. From the Tables 3.1 - 3.5, it should be ﬁrst noted that the ‘empiri-
cal’ variances are reasonably close to the true ‘optimal’ value only for high values of n
47(where n = E(ni) for all i), regardless of the number of trials and of the S2
i pattern con-
sidered. As n decreases, the ‘declared’ variance is less accurate and precise. In all cases,
however, the ‘optimal’ variance is badly underestimated. In particular, as the average
number of patients per arm decreases, the estimated ‘declared’ overall variances start
to deviate from the ‘optimal’ value with negative and increasingly large bias. Thus,
we can assume that the method currently used leads to large error in the estimated
weights, both when common or uncommon S2
i ’s are assumed. Moreover, considering
the column of the ‘actual’ variance of the estimator, V real(ˆ (θ)), we note that, once
again, these values are always observed to be higher than both the ‘optimal’ and the
‘declared’ ones, in particular when n decreases. Again, even without the assumption of
common S2
i for all studies, there is the tendency to produce an overall variance estimate
ˆ V that is lower than that produced by the ‘optimal’ estimator, whereas the ‘actual’
variance of the estimator is higher. Fixed-eﬀects meta-analysis uses an estimator whose
true variance is higher than the ‘correct’ one but which will appear to be lower. As a
consequence, the ordinary method tends to overstate the signiﬁcance and the precision
of the results; in particular, this tendency is even more marked under the assumption
of uncommon S2
i .
As regards the Empirical Coverage Probabilities for the Conﬁdence Intervals, the pro-
portion of intervals containing θ falls for decreasing sample sizes. Note that the coverage
probabilities for the conﬁdence intervals in Figs. 3.1 - 3.2 are also very similar, excep-
tion made for small values of n. Under diﬀerent levels of variance heterogeneity and
under diﬀerent schemes of simulation, patterns are about the same regardless the num-
ber of studies taken into account. The coverage probabilities based on the ‘declared’
overall variances are generally below 95%, although they do increase when n increases.
However, for an average number of patients per arm per study less than 10, the cov-
erage probability falls to 55%. For small sample sizes, the coverage probability is far
from the nominal level whether we consider the slightly imbalanced scenario or the
most imbalanced one. The diﬀerent choices of within-trial variances (S2
i ) do not have
an impact on the simulation results. As regards the number of trials, if the latter are
“large enough” then no matter how many studies we include we get roughly the same
results. On the contrary, if sizes are small, the more studies we consider the lower the
coverage probability is.
In short, the usual variance estimator performs very poorly in detecting the true vari-
ance of θ and underestimates the true value for all values of n and k. Moreover, the
‘actual’ variability of the variance estimator is always higher than both the ‘declared’
and ‘optimal’ ones, with a consequent overstatement of the precision of the estimator
and misleading results in the form of too liberal signiﬁcance tests and Conﬁdence In-
tervals without correct coverage properties. In particular, these problems arise when
48a small average number of patients per arm per study is considered: the smaller the
number of patients, the lower the coverage probability and the higher the overestima-
tion of the precision of the estimate.
When we perform ﬁxed-eﬀects meta-analysis, inference is based on the assumption
that weights are perfectly estimated, whereas since the variances are poorly estimated
the inferences drawn may be in error. In practice, no matter whether the true variances
are assumed to be equal or whether they vary from trial to trial, in both cases there is
the tendency to badly estimate V, the overall variance of the point estimate. Moreover,
regardless of the true values of S2
i , the fewer the average number of subjects per arm
the higher the underestimation of V. In fact, under the assumption of both equal S2
i ’s
(see Fig 2.3 and Table 2.2) and unequal S2
i ’s (see Tables 3.1 and 3.2), the empirical
coverage probabilities are generally below 95% and ﬁgures get closer to the nominal
level only for high values of n. For instance, referring to the empirical coverage proba-
bilities, we see that if n=8 and S2
i ’s are assumed to be equal, the coverage probabilities
are roughly between 87 and 89% (depending on the number of trials involved) whereas
under the assumption of unequal S2
i ’s these values may vary between 82 and 88%.
Since when performing a single meta-analysis the real values of the study variances
are unknown, little can be said about the assumptions on the variances. However,
regardless of the assumption made, a lot can be said about the expected outcome: if
small-sized studies are considered, the overall variance will be underestimated quite
badly and inferences based on these values are likely to be wrong.
49Table 3.1: The Results of Simulation for diﬀerent values of studies (k) under the
assumption of Unequal S2
i and Study sizes - First Simulation Scheme (A)
k = 10 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 5.787174 1.724529 1.090686 0.7069
8 1.716196 0.985787 0.822931 0.8691
10 0.951359 0.763757 0.681596 0.9041
15 0.537592 0.490154 0.462380 0.9274
20 0.380268 0.363268 0.348901 0.9400
30 0.245991 0.240309 0.233714 0.9439
50 0.144902 0.143970 0.141717 0.9471
k = 15 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 4.947632 1.087694 0.656184 0.6625
8 1.418933 0.631846 0.522482 0.8620
10 0.631725 0.496492 0.440474 0.8984
15 0.334990 0.323049 0.302369 0.9361
20 0.251068 0.240756 0.230016 0.9377
30 0.165133 0.159585 0.155199 0.9418
50 0.095679 0.095648 0.094113 0.9499
k = 20 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 4.892815 0.796330 0.467671 0.6373
8 1.258493 0.467765 0.386032 0.8506
10 0.492900 0.368996 0.326740 0.8989
15 0.257675 0.241634 0.225962 0.9319
20 0.191488 0.179803 0.171074 0.9346
30 0.122043 0.119628 0.116054 0.9473
50 0.073591 0.071738 0.070481 0.9428
k = 35 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 4.098463 0.436752 0.245839 0.5698
8 0.845240 0.262924 0.212878 0.8319
10 0.403127 0.207927 0.182103 0.8869
15 0.146905 0.137120 0.127746 0.9319
20 0.111066 0.102539 0.097383 0.9344
30 0.069944 0.068164 0.065977 0.9443
50 0.042369 0.040884 0.040116 0.9444
This Table shows the results of simulation for θ = 3 and diﬀerent values of n, k and S
2
i . This
simulation scheme considers for each simulation k parallel group clinical trials each of whom with the
same number of patients per arm only on average (n = E[ni] = nTi = nCi). As regards the
within-study variances, the most imbalanced scenario is shown, i.e. 80% of the studies has S
2
i set to
100 while the remaining 20% are set equal to 10. Empirical Statistics for E[ˆ V ] and V
real(ˆ θ) are based
on 10000 simulation replicates as well as the Empirical Coverage Probability.
50Table 3.2: The Results of Simulation for diﬀerent values of studies (k) under the
assumption of Unequal S2
i and Study sizes - First Simulation Scheme (B)
k = 10 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 2.917085 0.844070 0.519157 0.6988
8 0.822160 0.486116 0.401863 0.8652
10 0.496175 0.378410 0.335633 0.9046
15 0.261349 0.247350 0.231493 0.9344
20 0.197728 0.183608 0.175550 0.9333
30 0.125123 0.121904 0.118438 0.9419
50 0.075708 0.073157 0.071895 0.9423
k = 15 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 2.515061 0.567343 0.341732 0.6644
8 0.608366 0.335919 0.275871 0.8487
10 0.361150 0.263301 0.232215 0.8970
15 0.187226 0.172940 0.161681 0.9307
20 0.134901 0.129138 0.123035 0.9367
30 0.087392 0.085815 0.083122 0.9449
50 0.051520 0.051463 0.050523 0.9479
k = 20 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 2.050539 0.393981 0.231733 0.6381
8 0.599061 0.234913 0.191897 0.8494
10 0.271898 0.185648 0.162671 0.8943
15 0.132802 0.122398 0.114006 0.9269
20 0.097786 0.091385 0.086845 0.9353
30 0.062851 0.060831 0.058860 0.9422
50 0.036432 0.036428 0.035755 0.9480
k = 35 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 2.019225 0.222689 0.124061 0.5592
8 0.441426 0.135820 0.109607 0.8233
10 0.163837 0.107798 0.094237 0.8911
15 0.076543 0.071281 0.066329 0.9329
20 0.055763 0.053325 0.050581 0.9398
30 0.037028 0.035547 0.034353 0.9416
50 0.021329 0.021306 0.020883 0.9484
This Table shows the results of simulation for θ = 3 and diﬀerent values of n, k and S
2
i . This
simulation scheme considers for each simulation k parallel group clinical trials each of whom with the
same number of patients per arm only on average (n = E[ni] = nTi = nCi). As regards the
within-study variances, a slight imbalanced scenario is shown, i.e. 50% of the studies had S
2
i set to
100 while the remaining 50% were set equal to 10. Empirical Statistics for E[ˆ V ] and V
real(ˆ θ) are
based on 10000 simulation replicates as well as the Empirical Coverage Probability.
51Table 3.3: The Results of Simulation for diﬀerent values of studies (k) under the
assumption of Unequal S2
i and Study sizes - Second Simulation Scheme (A)
k = 10 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 4.81074E-04 1.53915E-04 1.08749E-04 0.8079
8 1.62910E-04 9.29367E-05 7.92131E-05 0.8982
10 8.81519E-05 7.32187E-05 6.63829E-05 0.9166
15 4.73614E-05 4.41435E-05 4.21259E-05 0.9340
20 3.37472E-05 3.30902E-05 3.18899E-05 0.9401
30 2.45493E-05 2.23964E-05 2.19227E-05 0.9460
50 1.37721E-05 1.37271E-05 1.35344E-05 0.9467
k = 15 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 1.55977E-04 3.99302E-05 2.74604E-05 0.8110
8 4.02419E-05 2.20131E-05 1.87943E-05 0.8924
10 2.36055E-05 1.80732E-05 1.64116E-05 0.9186
15 1.09118E-05 1.08852E-05 1.04165E-05 0.9363
20 8.53535E-06 8.35436E-06 8.01270E-06 0.9409
30 5.53268E-06 5.49154E-06 5.34444E-06 0.9469
50 3.13219E-06 3.05720E-06 3.02327E-06 0.9435
k = 20 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 7.25774E-05 1.43276E-05 9.27051E-06 0.8038
8 1.81251E-05 8.17075E-06 7.04632E-06 0.8961
10 8.29189E-06 6.33262E-06 5.79714E-06 0.9168
15 4.08453E-06 4.01735E-06 3.81904E-06 0.9387
20 3.49810E-06 2.87931E-06 2.81890E-06 0.9416
30 1.98370E-06 1.96991E-06 1.92363E-06 0.9424
50 1.26418E-06 1.25725E-06 1.23345E-06 0.9469
k = 35 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 1.25921E-05 1.79404E-06 1.17625E-06 0.8040
8 1.51794E-06 1.07902E-06 9.32548E-07 0.8943
10 1.19789E-06 7.97212E-07 7.20237E-07 0.9135
15 5.48354E-07 5.05667E-07 4.79389E-07 0.9365
20 3.33613E-07 3.52159E-07 3.37293E-07 0.9423
30 2.92712E-07 2.67102E-07 2.61131E-07 0.9437
50 1.57857E-07 1.57786E-07 1.55980E-07 0.9486
This Table shows the results of simulation for θ = 3 and diﬀerent values of n, k and S
2
i . This
simulation scheme considers for each simulation k parallel group clinical trials each of whom with the
same number of patients per arm only on average (n = E[ni] = nTi = nCi). In this simulation
scheme, within-study variances S
2
i are drawn from a Γ distribution with shape parameter γ = 0.25.
Empirical Statistics for E[ˆ V ] and V
real(ˆ θ) are based on 10000 simulation replicates as well as the
Empirical Coverage Probability.
52Table 3.4: The Results of Simulation for diﬀerent values of studies (k) under the
assumption of Unequal S2
i and Study sizes - Second Simulation Scheme (B)
k = 10 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.0515724 0.0155874 0.0098259 0.7165
8 0.0154709 0.0089368 0.0074546 0.8733
10 0.0085677 0.0069199 0.0061864 0.9128
15 0.0047821 0.0045230 0.0042589 0.9328
20 0.0034570 0.0032938 0.0031601 0.9386
30 0.0022969 0.0022170 0.0021583 0.9419
50 0.0013495 0.0013065 0.0012880 0.9441
k = 15 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.0409151 0.0088253 0.0053688 0.6775
8 0.0090774 0.0050160 0.0041460 0.8650
10 0.0059114 0.0039948 0.0035261 0.9031
15 0.0028288 0.0026268 0.0024566 0.9294
20 0.0020033 0.0019289 0.0018477 0.9389
30 0.0013050 0.0012869 0.0012500 0.9456
50 0.0007744 0.0007619 0.0007493 0.9491
k = 20 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.0357162 0.0059225 0.0035595 0.6558
8 0.0076422 0.0034974 0.0028850 0.8514
10 0.0036417 0.0027604 0.0024472 0.9059
15 0.0019467 0.0017814 0.0016727 0.9335
20 0.0013540 0.0013215 0.0012625 0.9374
30 0.0008975 0.0008707 0.0008459 0.9413
50 0.0005269 0.0005250 0.0005160 0.9447
k = 35 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.0242387 0.0028335 0.0016546 0.6036
8 0.0062553 0.0016724 0.0013653 0.8411
10 0.0019950 0.0013180 0.0011652 0.9047
15 0.0009610 0.0008661 0.0008112 0.9285
20 0.0006909 0.0006430 0.0006125 0.9327
30 0.0004454 0.0004323 0.0004194 0.9430
50 0.0002613 0.0002531 0.0002485 0.9468
This Table shows the results of simulation for θ = 3 and diﬀerent values of n, k and S
2
i . This
simulation scheme considers for each simulation k parallel group clinical trials each of whom with the
same number of patients per arm on average (n = E[ni] = nTi = nCi). In this simulation scheme,
within-study variances S
2
i are drawn from a Γ distribution with shape parameter γ = 1. Empirical
Statistics for E[ˆ V ] and V
real(ˆ θ) are based on 10000 simulation replicates as well as the Empirical
Coverage Probability.
53Table 3.5: The Results of Simulation for diﬀerent values of studies (k) under the
assumption of Unequal S2
i and Study sizes - Second Simulation Scheme (C)
k = 10 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.4561987 0.1399444 0.0849630 0.6901
8 0.1471794 0.0825180 0.0680434 0.8585
10 0.0846646 0.0644753 0.0569307 0.9009
15 0.0469084 0.0425057 0.0397063 0.9262
20 0.0333541 0.0316287 0.0301946 0.9319
30 0.0220455 0.0210269 0.0203818 0.9401
50 0.0128987 0.0125241 0.0123001 0.9414
k = 15 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.3793491 0.0894609 0.0525835 0.6501
8 0.1129277 0.0532958 0.0435367 0.8497
10 0.0592798 0.0422414 0.0371362 0.8974
15 0.0303040 0.0276316 0.0257761 0.9297
20 0.0222863 0.0208020 0.0198107 0.9350
30 0.0142411 0.0138214 0.0133774 0.9419
50 0.0086080 0.0082729 0.0081168 0.9428
k = 20 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.3520310 0.0653238 0.0374189 0.6112
8 0.0927032 0.0393147 0.0319142 0.8361
10 0.0445698 0.0312078 0.0274058 0.8933
15 0.0225143 0.0206696 0.0192208 0.9306
20 0.0162632 0.0153991 0.0146369 0.9386
30 0.0104935 0.0102330 0.0098997 0.9436
50 0.0063069 0.0061575 0.0060413 0.9475
k = 35 n V real(ˆ θ) V opt E[ˆ V ] Coverage
Probability
5 0.3044838 0.0361784 0.0197527 0.5428
8 0.0714990 0.0220422 0.0178129 0.8166
10 0.0264298 0.0175457 0.0153523 0.8938
15 0.0125205 0.0116370 0.0108208 0.9316
20 0.0092827 0.0087110 0.0082593 0.9357
30 0.0059134 0.0058103 0.0056140 0.9399
50 0.0035171 0.0034782 0.0034116 0.9478
This Table shows the results of simulation for θ = 3 and diﬀerent values of n, k and S
2
i . This
simulation scheme considers for each simulation k parallel group clinical trials each of whom with the
same number of patients per arm only on average (n = E[ni] = nTi = nCi). In this simulation
scheme, S
2
i are drawn from a Γ distribution with shape parameter γ = 4. Empirical Statistics for E[ˆ V ]
and V
real(ˆ θ) are based on 10000 simulation replicates as well as the Empirical Coverage Probability.
54Under the assumptions of both common and uncommon S2
i , the average number of
patients per arm per clinical trial plays an important role since for small values of n
there is the tendency to badly underestimate V , the overall variance of the estimator.
Speciﬁcally, we have pointed out that the usual variance estimator commonly used in
meta-analytical inference is not robust to the estimated weights, and that in fact it may
not be a good estimator for the correct variance of an overall eﬀect estimate when esti-
mated weights are used, as in practice. Hence, the weights used in practice are not the
correct ones and a new method to better estimate the variances ˆ σ2
i (and the weights)
in order to have a more precise and accurate overall variance is desperately needed.
For instance, should there be some random variation in the treatment or control group
sample variances that causes an extremely small pooled variance, the variance of the
mean diﬀerence ˆ σ2
i will badly underestimate the true one and the weight of this in-
dividual sample will be too high. Since the ordinary method is too sensitive to the
variation of the sample variances and biased if the sample size is not large “enough”
(being small variances more suspicious for small studies), is there a robust method to
adjust weights with regard to the variation of S2
i and sample sizes and not too sensitive
to any individual result?
In order to minimise the overall variance estimation error and to have better weights
a shrinkage estimator for within trials variances S2
i will be taken into account. This
should guarantee enough robustness in order to provide protection against errors in the
estimated weights (i.e. random variation in sample variances); this way, the ‘declared’
estimated variance should be closer to the optimal one, more importantly, the ‘actual’
variability of the overall eﬀect estimator computed with the new weights should be
closer to both the ‘optimal’ and the ‘declared’ values. The dispersion of the variances
around the optimal value will be an indicator of the goodness of the method used.
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573.4 Shrinkage Estimators
3.4.1 Basic Logic
The ‘Shrinkage Estimators’ are commonly considered consistent with Bayesian logic
since their main idea is that, when estimating a parameter, one should not simply use
the information coming from the sample, but also some ‘extra-sample’ information.
In fact, combining measurements (i.e. estimating single parameters using some sort of
overall information) minimises the total ’Mean Squared Error’ (MSE). When the nature
of the problem is not to estimate each expected return separately but rather minimise
the total impact, shrinkage estimators represent an eﬃcient and reasonable alternative
to the classical estimators. In this study it is therefore reasonable to combine variance
measurements since the goal is to minimise the total variance estimation error.
Considering both the informative prior and the information obtained through the sam-
ple, the shrinkage estimators compress the general values of each single study towards
an identical common value (usually referred to as the ‘common mean’ or informative
prior) (Braga, 2004). In fact, the general logic of a shrinkage estimator is similar to the
weighted mean of a ‘common value’ and a ‘sample mean’ where weights determine how
close the expected value is to the common one that functions as a target. There are
several approaches to shrinking least squares estimators towards a common mean; all
of which suggest that in general shrinking “produces estimators with greater predictive
power than classical pooling techniques” (Smith, 1997, pg. 359).
The ‘shrinking factor’ is the element that determines the intensity of the ‘shrinking’
towards the ‘mean value’ and therefore this is the element that tells us the proximity
of the informative prior to the sample information at disposal. The shrinking factor
is quantiﬁed accordingly to the informative prior used, that is the value of the ‘com-
mon mean’ assumed. Usually the ‘common mean’ depends on the sampled values;
that is the reason why the shrinkage estimators have similarities with the empirical
Bayes approach. In general, the ‘shrinking factor’ is inﬂuenced by the dimension of the
study, the total number of studies included as well as the dispersion of the single values
around the common mean (Braga, 2004). The eﬀect of the empirical Bayes approach
is to smooth estimates based on small numbers of events more heavily than estimates
based on large numbers of events (Cox & Solomon, 1997).
3.4.2 An introduction to Stein-Estimators
“Stein (1956) obtained the surprising result that for estimating p independent normal
means simultaneously, the sample mean was inadmissible under squared error loss when
p ≥ 3”(Ghosh et al., 1983, pg. 351). In this case (p ≥ 3), “the cost of estimating the
shrinkage intensity is already (and always!) oﬀset by the savings in total risk” (Opgen-
58Rhein & Strimmer, 2007, pg. 4).
Stein’s paradox (or phenomenon or problem) mainly demonstrated that when 3 or
more parameters are estimated simultaneously, their combined estimator is more accu-
rate than any other method which handles the parameters separately, even when the
measurements and the parameters are totally unrelated. In fact, the combined estima-
tor achieves a lower MSE and – even if not necessarily better estimates for the single
variable alone are obtained – a better estimate (which has a reduced total risk) for the
means of all of the random variables is produced. Surprisingly, the cost of a bad esti-
mate in one component can be compensated by a better estimate in another component.
When multiple observations are present (no matter whether those observations are sta-
tistically independent), the simultaneous measurement of several parameters reduces
the total error of the parameters. Such a correction to the reduced mean squared error
can be obtained by shrinking the ordinary estimator. For example the MSE of the MLE
of the variance of the normal distribution can be reduced by shrinking the estimates
toward zero. (Hedges & Olkin, 1985). Furthermore, recent studies have demonstrated
that in many cases “shrinking towards a data-based point yields more reduction in
risk than shrinking towards the origin” (Ghosh et al., 1983, pg. 353). In general, it
is sensible to use a shrinkage estimator when it is reasonable to expect the values to
be quite close together and the possibility of an overall improvement in the estimates
at the expense of a worsening of individual ones is considered acceptable or desirable
(Cox & Hinkley, 1974). Shrinkage technique has been used in diﬀerent problems and
under diﬀerent assumptions and settings, both in simultaneous estimation problems
for normal, exponential or non-normal distributions (Ghosh et al., 1983). In practice,
in fact, there are several situations where it is a requirement to shrink the usual plain
estimators in order to obtain a uniformly smaller risk than the usual plain estima-
tor. Surprising results have been shown in the estimation problems of the variance; in
particular, in small sample problems the concept of shrinkage has been recognised as
beneﬁcial. (Kubokawa, 1999).
3.4.3 Properties of the Shrinkage Estimators
While the Bayes estimators make use of the prior knowledge, the usual procedures such
as UMVUE and MLE neglect such a knowledge. The empirical Bayes estimator, on
the contrary, can be interpreted as an intermediate of the Bayes and usual ones as this
incorporates parts of the prior information (guessed or taken from the sample) even if
one cannot suppose any exact prior information.
The empirical Bayesian approach to shrinking naturally allows for information sharing
across studies, which can be important especially when the number and sizes of studies
considered are small. In fact, even though “analytic shrinkage estimators combine
properties that render them attractive for analyzing large-dimensional studies” (Opgen-
59Rhein & Strimmer, 2007, pg. 2), these can be used for small-dimensional studies as
well. Moreover, shrinkage estimators are generally fully analytic and usually require no
computer-intensive procedures and only little distributional assumptions.
3.5 Why draw on Bioinformatics?
In this research, we use an estimator of the error variance that can borrow information
across studies using the James-Stein shrinkage concept. Tong et al. (Tong & Wang,
2007), in particular, employed James-Stein Estimation, further developing the estima-
tor by Cui et al. (2005), to obtain shrinkage estimates of the gene-speciﬁc variances,
making only weak prior assumptions about the distribution of the variance components
(the sampling distribution of the logarithm of the variance estimators is assumed to be
normal) and achieving an estimator with an explicit expression that is computationally
simple. Such an estimator was originally used for microarray experiments. In the
original paper, a new test statistic was developed based and constructed on this shrink-
age estimator and this provided “a powerful and robust approach to test the diﬀerential
expressions of genes that utilises information not available in individual gene testing
approaches and does not suﬀer from biases of the pooled variance approach” (Cui et
al., 2005, pg. 59).
Similarly to the meta-analysis, combining information across genes in the statistical
analysis of microarray data is desirable because of the relatively small number of data
points obtained for each individual gene. Small number of freedom due to few repli-
cates is a common situation for microarray experiments (Lin et al., n.d.). In fact, since
microarrays are expensive, experiments are typically performed with a limited number
of replicates. When this is the case, the use of within-gene estimates of variability
provides unreliable results (Jain et al., 2003). Speciﬁcally, if variance heterogeneity is
assumed, individual gene-speciﬁc tests are used even though the standard gene-speciﬁc
estimators of variances are unreliable due to the relatively small number of replica-
tions (Cui et al., 2005). On the other hand, more powerful tests can be used assuming
common variance; nevertheless, this assumption is unlikely to be true. “Thus, tests
based on a pooled common variance estimator for all genes are at the risk of generating
misleading results” (Tong & Wang, 2007, pg. 113).
“A number of approaches to improving estimates for variability and statistical tests
of diﬀerential expression have thus recently emerged. Several variance function meth-
ods have been proposed” (Jain et al., 2003, 1945). In particular, over the last few
years, shrinkage approaches that combine variance information across genes have been
developed. Tests based on variance estimates that are gene speciﬁc but combine in-
60formation across many genes are nowadays considered better approaches in microarray
experiments in order to increase power by utilizing more information in the data and
also to avoid bias (Cui et al., 2005). These approaches were usually proposed to handle
better “the situation where a gene with low expression may have very low variance by
chance” (Jain et al., 2003, pg. 1946).
Meta-analysis, i.e. a combination of results and information from independent quanti-
tative investigations, shares somehow the same problems with microarray experiments.
Also in meta-analysis, both the sample size within individual studies and the number of
studies are typically relatively small. This is the reason why the treatment and control
group sample variances as well as the ˆ σ2
i may be unreliable and, as a consequence, the
reported overall variance is less than the optimal value. Tests based on the common
overall variance estimator for all studies are at risk of generating misleading results in
meta-analyses as well (too liberal signiﬁcance tests and Conﬁdence Intervals without
correct coverage properties). As in meta-analysis one is usually interested in the possi-
bility of an overall gain (i.e. a better estimate of the overall variance of the estimator
rather than merely better individual estimates ˆ σ2
i ) and as the setting and problems
faced are similar to those which crop up in Bioinformatics, we decided to borrow the
shrinkage estimator (originally developed for microarray problems) to evaluate whether
this would be useful in a meta-analysis context as well. Moreover, the speciﬁc modiﬁed
shrinkage estimator used in our simulations usually require little assumptions and is
therefore easily adaptable to diverse and numerous frameworks. “Even though moti-
vated and applied to microarray data, the optimal shrinkage variance estimator [...]
can have a wide range of applications”. Tong and Wang “methodology and theory
extend Stein’s landmark results from shrinkage estimation of means to shrinkage esti-
mation of variance, and from shrinkage estimation of a single variance to the shrinkage
estimation of multiple variances” (Tong & Wang, 2007, pg. 121).
3.6 Shrinkage Statistic of Variance Vector: method used
A shrinkage estimator for gene-speciﬁc variance components based on the James-Stein
estimator was proposed by Cui et al in 2005 (Cui et al., 2005). Their estimator made
no prior assumptions about the distribution of variances across genes. The test based
on such an estimator performed well under a wide range of assumptions about vari-
ance heterogeneity, behaving well both when the variances were truly constant as well
as when they varied extensively from gene to gene. How did they obtain a shrinkage
estimator of variance components that provided a gene-speciﬁc variance also using in-
formation across all of the genes in the data in order to improve estimation?
Stein discovered that the standard sample variance is improved by a shrinkage esti-
61mator using information contained in the sample mean. Much research has been done
since then. Nevertheless, most research concerned with a single variance, assumption
not applicable to microarray data analysis since the homogeneity of the variances is
unlikely to be true. Cui et al. focused on heterogenous variances and, instead of using
information in the sample mean, extended Stein’s theory for multiple means to multi-
ple variances. This way they obtained variance estimates that were gene-speciﬁc but
combined at the same time information across many genes, improving power but also
avoiding bias. Cui et al. method was recently further developed and improved by Tong
and Wang who presented their methods in the framework of microarray data analysis,
stressing however that both their methods and theory are general may be implemented
in a much wider range of scenarios (Tong & Wang, 2007).
3.6.1 CHQBC Estimator
As initially suggested by Cui et al. (2005), an improved estimator of variance from an
ensemble of individual variance estimators (herein referred to as the CHQBC estima-
tor) can be constructed by shrinking them towards their common corrected geometric
mean. “The amount of shrinkage depends on the variability of the individual variance
estimators. When individual variance estimates are similar, indicating homogeneity,
the shrinkage estimator eﬀectively pools these estimates. When individual variance
estimates are widely dispersed, indicating heterogeneity, the shrinkage estimator gives
greater weight” to the study speciﬁc contributions (Cui et al., 2005, pg. 61).
For g = 1, ..., G (G ≥ 3 with G equal to the number of studies), let Xg be the residual
sum of squared errors and σ2
g be the true variance of g. Assuming that Xg/σ2
g’s are
mutually independent (each having a Chi-squared distribution χ2
ν with ν degrees of
freedom) we have Xg ∼ σ2
gχ2
ν. Considering the natural logarithm transformation of Xg
we then have
ln
Xg
ν
∼ lnσ2
g + ln
χ2
ν
ν
Therefore, if we denote the mean of ln
χ2
g
ν as m, by subtracting m from both sides we
could write the following equation
X0
g ∼ lnσ2
g + 0
g
where X0
g = ln(Xg/ν)−m and 0
g = ln(χ2
ν/ν)−m. Applying the James-Stein shrinkage
method to X0
g and then transforming back to the original scale gives the shrinkage
estimator for σ2
g,
˜ σ2
g =


G Y
g=1
(Xg/ν)1/G

B ∗ exp
"
1 −
(G − 3)V
P
(lnXg − lnXg)2

+
∗ (lnXg − lnXg)
#
(3.1)
where V is the variance of 0
g, lnXg = 1
G
PG
g=1 ln(Xg) and B = exp(−m) is a bias
correction (all the details are provided by Cui et al. (2005)). “Note that multiplying
62the geometric mean
QG
g=1(Xg/ν)1/G

by B gives an unbiased estimator of σ2 when
σ2
g = σ2 for all g. The values of B (and also V) depend on ν. They can be simulated
easily and values are given in Table 3.6. Note that B is always larger than 1, hence,
the geometric mean without B underestimates σ2 when all σ2
g are equal to σ2” (Cui et
al., 2005, pg. 61).
Table 3.6: Values of B (bias correction) and V/(2/ν) as a function of ν.
ν B V/(2/ν) ν B V/(2/ν)
1 3.53 2.45 13 1.08 1.08
2 1.77 1.64 14 1.08 1.08
3 1.44 1.39 15 1.07 1.07
4 1.31 1.27 16 1.07 1.06
5 1.24 1.22 17 1.06 1.06
6 1.19 1.18 18 1.06 1.06
7 1.16 1.15 19 1.06 1.05
8 1.14 1.13 20 1.05 1.05
9 1.12 1.12 25 1.04 1.04
10 1.11 1.11 30 1.04 1.03
11 1.10 1.10 40 1.03 1.03
12 1.09 1.09 50+ 1.02 1.02
These values are used in equation 3.1 to construct the estimates that shrink the unbiased estimators
of variances to their corrected geometric mean. When ν is greater than 50, B and V/(2/ν) are
eﬀectively 1.
3.6.2 Improvements on the CHQBC Estimator
Even though the CHQBC estimator may work well as an estimator of variance, Tong
and Wang (2007) suggested an improvement to such an estimator (for full details,
refer to the article). Let Zg = Xg/ν, Zpool =
QG
g=1 Z
1/G
g and ˆ α0 = 1 − (1 − (G −
3)V/
P
(lnXg − lnXg)2)+. It is easy to check that the CHQBC estimator can be
rewritten as
˜ σ2
g = B(Zpool)α(Zg)1−α with α = ˆ α0.
Note that when σ2
g = σ2 for all g, E(Zpool) = σ2/B. That is, BZpool is an unbiased
estimator of σ2 when σ2
g = σ2 for all g. On the other hand, Zg is an unbiased estimator
of σ2
g. Therefore, it is reasonable to consider the following combination of two unbiased
estimators
σ2+
g = (BZpool)α(Zg)(1−α), 0 ≤ α ≤ 1. (3.2)
Referring to σ2+
g ( ˆ α0) as the modiﬁed CHQBC estimator, σ2+
g ( ˆ α0) in the simulations
63shown always performs better than the original CHQBC estimator ˜ σ2
g( ˆ α0) for estimating
σ2
g. “The estimator σ2+
g has a very simple structure; it borrows information across
studies by shrinking each speciﬁc variance towards the bias corrected geometric mean
of variances for all studies. The amount of shrinkage depends on the variability of the
individual variances. In particular, the shrinkage parameter ˆ α was obtained by applying
the James-Stein method to the logarithm of sample variances which do not follow
the normal distribution” (Tong & Wang, 2007, pg. 114). “Although the James-Stein
shrinkage estimator was developed in a context of a normal model, it is the sampling
distribution of the logarithm of the variance estimators, not the values themselves,
that are assumed to be normal” (Cui et al., 2005, pg. 73). On the logarithm scale, the
modiﬁed CHQBC estimator is a weighted average of the study-speciﬁc variance and the
bias corrected geometric mean. If the empirical variances can be reliably determined
from the data, and consequently exhibit only a small variance themselves, there will be
little shrinkage, whereas if the empirical variance is comparatively large pooling across
studies will take place.
According to Tong and Wang simulations, “the modiﬁed CHQBC estimator σ2+
g ( ˆ α0)
has smaller risk than the original CHQBC estimator ˜ σ2
g( ˆ α0) in all settings” (Tong &
Wang, 2007, pg. 117), in particular when the variance heterogeneity and ν are both
small.
3.7 Comparison of methods by Simulations
We perform simulation studies to compare ˆ V , the usual overall variance estimator which
uses the estimated within variances, with ˆ V ∗, the estimator that takes into account the
‘shrunk’ variances. We then consider the ordinary estimators ˆ θ and ˆ V as in equations
2.3 and 2.4 with ˆ wi = 1/ˆ σ2
i where
ˆ σ2
i = ˆ S2
i

1
nTi
+
1
nCi

with ˆ S2
i =
(nTi − 1)ˆ s2
Ti + (nCi − 1)ˆ s2
Ci
nTi + nCi − 2
When ‘shrunk’ variances are considered, we denote the ‘new’ point and overall variance
estimators as follows
ˆ θ∗ =
Pk
i=1 ˆ w∗
iYi
Pk
i=1 ˆ w∗
i
and ˆ V ∗ =
1
Pk
i=1 ˆ w∗
i
(3.3)
where
ˆ w∗
i =
1
ˆ σ2
si
with ˆ σ2
is = ˆ S2
shr.i

1
nTi
+
1
nCi

(3.4)
where ˆ S2
shr.i’s are obtained with the shrinkage estimator (see eqn 3.2) applied on ˆ S2
i ’s.
The empirical coverage probabilities of the two Conﬁdence Intervals based on ˆ V and
ˆ V ∗ are computed and compared as well.
64Since it is known that errors are present in the estimated sample variances, the objec-
tive of this study is to evaluate whether the ‘improved’ CHQBC estimator improves the
behaviour of the overall variance estimates, i.e. to establish whether ˆ V ∗ performs in
general better than ˆ V . More speciﬁcally, we want to evaluate the robustness, precision
and accuracy of the overall variance estimator used in ﬁxed-eﬀects meta-analysis when
‘shrunk’ estimates of the pooled variances are used. Theoretically, the shrinkage esti-
mators for the pooled variances should better handle the situation when a single study
carry a disproportionate amount of weight and has few subjects and a very low sample
variances just by chance; moreover, ‘shrunk’ variances should take into consideration
the eﬀect of study sizes as well. ˆ V ∗ should therefore be less sensitive to any individual
results.
In order to assess and evaluate the goodness of the estimator whose weights are based
on the ‘shrunk’ variances, the dispersion around the optimal value will be computed.
In particular, non only ˆ V ∗ should yield values on average closer to the optimal levels,
but also the ‘real’ dispersion should not be too imprecise nor be too far from both the
‘declared’ and the ‘optimal’ values.
Simulation settings are as speciﬁed in section 3.2. In addition, the common variance
scenario is considered, i.e. the case where S2
1 = 100 for all i. Results are given in
tables 3.7 - 3.12 for the diﬀerent S2
i settings. Each table shows the Conﬁdence Inter-
vals based on both ˆ V and ˆ V ∗. Moreover, since when we simulate studies we have the
privilege to know the ‘real’ values of each single within study variances, the average
(over 10000 replicates) ‘optimal’ overall variance of the estimator is calculated. The
‘declared’ and ‘actual’ dispersion for both methods are also given. Furthermore, in
order to make comparisons between the two methods easier, ratio index numbers are
shown in columns 10-15. Ratio Index numbers measure changes or diﬀerences and are
used in a variety of contexts to compare series of numbers of diﬀerent size in a standard-
ised and directly comparable way. An index number is generally formed by the ratio
between the ‘current value’ of an indicator and its ‘base value’, against which all the
observations are measured and compared. The ratio itself has no units and expresses
the changes around the base. In Tables 3.7 - 3.12, columns 10 and 11 are the ratio
between the ‘real’ dispersion of the estimator and its ‘declared’ value, for ˆ V and ˆ V ∗
respectively. Values in these columns indicate how much larger the ‘real’ dispersion is
compared to the ‘declared’ one; the bigger the value, the wider the absolute diﬀerence
between the two numbers. Columns 12 - 15 show the ratio between either the ‘real’ or
the ‘declared’ variances (for both ˆ V , ˆ V ∗) and the ‘optimal’ value which is the base for
all four columns. Values less than 1 mean that there is a negative bias in the estimate
while values greater than 1 indicate the opposite. The ideal situation would be to have
both the ratio of the ‘declared’ and the ‘real’ dispersion to the ‘optimal’ equal to 1,
65indicating perfect estimation of the overall variance of the estimator.
From the results in Tables 3.7 - 3.12, we note that ˆ V ∗ always perform better than
ˆ V . Observing the absolute values, the estimator that uses weights based on the vari-
ance shrinkage estimator has values closer to the ‘optimal’ ones. In particular, not
only is the ‘declared’ variance closer to the ‘optimal’, but the ‘real’ dispersion is also
not badly estimated. This means that the new method tends to underestimate the
‘optimal’ value less severely, on average and in all cases. In practice, when performing
a single meta-analysis, with the new method we tend to declare on average a variability
of the point estimate closer to the correct one; moreover, the ‘real’ dispersion of the
new method is smaller than the one obtained with the ordinary estimator, meaning
that the new method yields less liberal results because of the slight diﬀerence between
the ‘real’ and the ‘declared’ dispersion of ˆ V ∗. As a consequence, in general we still
tend to overstate the precision of the estimator, but less badly. In fact, observing the
absolute values, we can note that the following relationship always hold
V real(ˆ θ) ≥ V real(ˆ θ∗) ≥ V opt
As regards the ‘declared’ variances, in general we have ‘
V opt ≥ E[ˆ V ∗] ≥ E[ˆ V ]
Nevertheless, it may happen that the ‘average’ declared variance obtained using the new
method is slightly larger than the ‘optimal’ value. Again, if we consider the absolute
diﬀerence between the ‘optimal’ and the ‘declared’ variances obtained with the usual
and the new methods, such a diﬀerence is always smaller when the new method is taken
into account. For instance, when n > 10, the new method may declare a variance 1%
greater than the ‘optimal’ instead of underestimating it by between 3 and 12%. In
the worse scenario (Table 3.10), when n=5 and k=35, the new method overstates the
variance by 10% whereas the usual method underestimates it by 35%.
In general, however, the following relationship holds
V real(ˆ θ) ≥ V real(ˆ θ∗) ≥ V opt ≥ E[ˆ V ∗] ≥ E[ˆ V ]
This relationship is conﬁrmed even when ratio index numbers are taken into consider-
ation. The ratio V real(ˆ θ∗)/E[ˆ V ∗] is always smaller than V real(ˆ θ)/E[ˆ V ], entailing that
the variability (and range) of the new method is smaller than the one obtained with the
usual method. In addition, from columns 12 to 15 we note that, given 1 as the optimal
value, both V real(ˆ θ∗) and E[ˆ V ∗] are closer to the target 1. If the diﬀerence between
the two methods is almost imperceptible when n is large, this becomes dramatically
important when small studies are combined. For instance, Table 3.12 shows that for
n = 5 the ‘optimal’ variance is underestimated on average by only around 15% with
66the new method instead of 40% or more with the ordinary method. It is worth to
noting that even when n increases, both V real(ˆ θ∗) and E[ˆ V ∗] are more accurate and
less dispersed around the ‘optimal’ value.
As a consequence, turning to the empirical coverage probabilities of the the 95% Con-
ﬁdence Intervals for the two methods, we note that with the new method values are
always closer to the nominal value (and only in few occasions above the nominal level).
Especially when n is small, the coverage probabilities for the interval based on ˆ V ∗ are
much better than the usual ones. They still suﬀer from inadequate coverage; never-
theless, the estimated Coverage probabilities of the CIs based on ˆ V fall well below the
ones obtained with the new method whose weights were shrunk.
These results generally emphasise that the estimator based on the ‘shrunk variances’
rather than the estimated ones performs better. Regardless of the variance structure
across studies (homoscedasticity or uncommon variances), the ordinary method shows
values close to the optimal only if large sized studies are summarised. The new method,
on the other hand, performs optimally even with an average small number of patients
per trial. ˆ V ∗ shows a certain accuracy and ﬂexibility since better results are achieved
even when variances are strongly heterogenous. It is quite remarkable that the new
method based on the shrinkage estimators proposed by Tong and Wang performs well,
providing highly accurate overall variances for simulated data for all considered scenar-
ios without relying on computational expensive procedures.
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753.8 Real Data Examples
In this section, as examples to illustrate the two methods compared and discussed in the
previous sections 4 data sets are taken into consideration. In particular, meta-analyses
and data sets given in Rees et al. (2004), Thompson & Pope (2005), Whitehead (2002)
and Salpeter et al. (2002) are presented in Figs 3.5 - 3.8 (For full details on trials,
heterogeneity tests, response variables and protocols for inclusion of studies, refer to
the full articles). These data-sets were considered as reasonable real examples on which
to apply the meta-analytical ‘shrunk’ estimator since the ﬁxed-eﬀects method was orig-
inally used to combine these data. Moreover, the variable of interest is in all cases
a continuous variable, assumed to be normally distributed, and summarised with a
weighted absolute mean diﬀerence (as in our simulations). Furthermore, what made
these data-sets particularly appealing to our study was the average number of patients
per arm as well as the diﬀerent number of studies combined together. For instance,
in the exercise duration studies (Rees et al. (2004)) we can observe a total of 510 ran-
domised participants measured in 15 studies with an average of 17 patients per arm
(cf. Fig. 3.5). Fifteen trials involving 22 patients per arm on average (cf. Fig. 3.6)
were selected to compare the frequency of Raynaud’s Phenomenon (RP) attacks over a
1-week period in those taking calcium channel blockers vs. placebo (Thompson & Pope
(2005)). A multicentre study with 9 centres (cf. Fig. 3.7) considered as being from
separate studies each of which with an average of 10 patients per arm were included
in a ﬁxed-eﬀects meta-analysis comparing two anaesthetic agents in patients undergo-
ing short surgical procedures (Whitehead (2002)). Finally, twenty-ﬁve studies each of
which including an average of 13 patients per arm were included to compare single-dose
of cardioselective β-blockers with placebo (cf. Fig. 3.8). The latter data-set, however,
could not be used for our purpose of illustrating and comparing results from the two
methods; in fact, an error in the printed table was present and, despite the access
to the original article (Chatterjee, 1986) the reproducibility of the same output as in
Salpeter et al. (2002) was not possible. Therefore, analysis was performed (using again
the statistical package R) only on the remaining data-sets.
Recall that the parameter of interest is the overall eﬀect, denoted by θ. The ﬁxed-
eﬀects model is assumed to be the correct one for our analysis, i.e. θi = θ for i = 1,2,
...k. This implies that the estimated eﬀect size Yi is normally distributed with mean
θ and variance σ2
i . The estimator of θ is generally a simple weighted average of the Yi,
with the optimal weights proportional to wi = 1/var(Yi). In practice, the variances
are not known so estimated variances ˆ σ2
i are used to estimate both θ and V=var(θ).
Hence we deﬁne ˆ wi = 1/ˆ σ2
i giving
ˆ θ =
P
ˆ wiYi P
ˆ wi
and ˆ V = var(θ) =
1
P
ˆ wi
76with
var(Yi) = ˆ σ2
i =

1
nTi
+
1
nCi

ˆ S2
i
where, generally, ˆ S2
i is equal to the within-study pooled variance calculated by
ˆ S2
i =
(nTi − 1)ˆ s2
Ti + (nCi − 1)ˆ s2
Ci
nTi + nCi − 2
This is the ordinary method usually used in ﬁxed-eﬀects meta-analysis. However, re-
sults will be given also when within-study variances are estimated via the modiﬁed
shrinkage CHQBC estimator (see equation 3.2). Both the formulae to compute the
point estimate θ and its overall variance V are the same but S2
shr.i instead of S2
i is used
to calculate var(Yi), where S2
shr.is are obtained with the shrinkage estimator (see eqn
3.2) applied on S2
i s (as thoroughly described in section 3.6), i.e.
ˆ S2
shr.i = (BZpool)α(Zg)(1−α), 0 ≤ α ≤ 1.
This estimator borrows information across studies by shrinking each speciﬁc variance
towards the bias corrected geometric mean of variances for all studies, where the amount
of shrinkage depends on the variability of the individual variances.
Moreover, these results will be given even under the assumption of a common within-
treatment group variance across all studies. This entails that not every study has its
own variance term and the common group variance across studies is estimated by S2
p
where
ˆ S2
p =
Pk
i=1(nTi + nCi − 2)ˆ S2
i Pk
i=1(nTi + nCi − 2)
Usually the decision to assume a common variance can be based upon Bartlett’s test,
even though strict adherence to a speciﬁc level for this test is not advisable and this
test is extremely sensitive to non-normality of data (Whitehead, 2002).
Therefore, 3 diﬀerent methods to calculate var(Yi) = ˆ S2 (1/nT + 1/nC) are consid-
ered; ˆ S2 can be replaced by the overall pooled variance ˆ S2
p, by the usual within-study
pooled variances ˆ S2
i or by the shrunk variances ˆ S2
shr.i leading to 3 diﬀerent estimates
of the variance of the mean diﬀerence, i.e. ˆ σ2
pi, ˆ σ2
i and ˆ σ2
si respectively. In general, we
would expect the change in the weights due to diﬀerent ways to calculate the variances
to lead to a change in the overall ﬁxed-eﬀect estimate of treatment diﬀerence and in
particular a change in the estimate of the variance of the overall eﬀect. In particular,
we expect V to be higher and more reliable when shrunk estimates are used.
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81Randomised controlled trials were used in the Cochrane meta-analysis (Table 3.13)
to determine the eﬀectiveness of exercise based interventions. In the meta-analysis
performed with the pooled variances, signiﬁcant improvements were seen for exercise
duration which increased by 2.38 minutes. Roughly the same point estimate is ob-
tained when ‘shrunk’ variances are taken into consideration;furthermore, as expected,
the variance of the overall estimator increases with the new proposed method. As illus-
trated through simulations we expect ‘shrunk’ variances to produce an overall variance
estimate whose ‘real’ and ‘average’ dispersion are both closer to the optimal value;
therefore, the bigger standard error of ˆ θ∗ should be closer to and less negatively biased
than the true value. Similarly, the 95% Conﬁdence Interval [-1.912 ; -2.864] is supposed
to have coverage properties more likely to be correct.
Looking at table 3.14, 15 studies were used in a ﬁxed-eﬀects meta-analysis to detect
whether calcium channel blockers would signiﬁcantly reduce, compared to the placebo,
the frequency of ischemic attacks in a 1-week period of time. Again, both the point
estimate and the overall variance diﬀer slightly depending on the method we are ap-
plying to the data-set. In fact, whilst the reduction between CCB and placebo has a
weighted diﬀerence mean of -2.802 if the pooled variances are considered, the reduction
is equal to -2.759 when ‘shrunk’ variances are taken into account. Moreover, the overall
variance estimate increases from 0.313 to 0.327 with the new method: this means that
the conﬁdence intervals for the new estimate obtained with ‘shrunk variances’ are wider
(95% CI [ -3.88 ; -1.64]). Again, we believe that the CIs obtained considering ‘shrunk’
variances are more likely to have correct coverage properties and that the declared
precision of the overall estimate should underestimate less remarkably the true value.
In this real-data example, it is interesting to note that Rodeheﬀer and Kahan-DILT
studies (i.e. 1 and 4) decrease their relative weights as expected. The original control
and treatment sample variances are extremely small compared to the other studies.
Not necessarily one has to expect these values similar to the other studies with the
same number of subjects but, at the same time, it is reasonable to suspect that these
values might be unreliable. Therefore, with the shrunk variances, the relative weight
of these 2 studies decreases, accounting this way for the possible imprecision of the
measures due to the small number of subjects; in particular, Rodeheﬀer’s weight drops
to 15.3% from the initial 17.8% while Kahan-DILT’s weight goes from 11.5% down to
10.7%.
Table 3.15 gives the estimates from the the log-recovery time meta-analysis, present-
ing details for diﬀerent methods to calculate the within-study variances. Interestingly,
we can observe that all centres have approximately the same weights regardless of the
method used. Nevertheless, centres 1, 3, 4 and 9 have, with the new shrunk estimates, a
82slightly higher weight in the ﬁxed-eﬀects meta-analysis. The change in the weights due
to the use of shrunk variances has led to a decrease in the overall ﬁxed-eﬀects estimate
of treatment diﬀerence. In particular, the new overall point estimate (i.e. diﬀerence
in mean log-recovery time after anaesthesia between treatment A and treatment B)
is equal to 0.611, showing that the recovery time (minutes from when the anaesthetic
gases are turned oﬀ until the patient opens their eyes) is longer on anaesthetic A than
on B. Not only has the point estimate changed but also has the overall variance V;
in fact, the standard error of ˆ θ∗ is equal to 0.101 and this should, according to the
simulations done, better represent the real variability of the estimator. This gives even
wider conﬁdence intervals which are supposed to have a coverage probability closer to
the nominal value of 95%.
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86Chapter 4
Conclusions and Discussion
Meta-analysis is the statistical summary of a collection of analytic results from indi-
vidual studies for the purpose of integrating the ﬁndings. Data-analysis is only the last
step of a long and complicated research synthesis procedure; the outcome of a meta-
analysis may therefore be a long awaited process. Furthermore, conclusions obtained
through such a quantitative research synthesis can have an important impact and sub-
stantial consequences in public and health planning policies. Clearly, “an estimate of
the overall eﬀect size should be accompanied by a conﬁdence interval to indicate the
precision with which the overall eﬀect size has been estimated” (Viechtbauer, 2007,
pg. 50). As a consequence, reliability of the output and in particular of the measure of
precision of the point estimate is crucial; a correct value of the standard error of the
point estimate ensures that the resulting signiﬁcance of the analysis is correctly stated
and that conﬁdence intervals have correct coverage probabilities. On the contrary, sta-
ting an incorrect precision can often result in biased and misleading results.
In this thesis, reliability of the overall variance of the point estimate was investigated
in ﬁxed-eﬀects meta-analyses since, in this case, the weights, the overall point estimate
θ, as well as its variance V depend entirely and solely upon the within-study variances,
usually assumed to be known. Nonetheless, this assumption is approximately true only
when sample sizes are large enough. Imprecision of the within-study variances should
not be simply ignored: in fact, when sampling errors are not taken into account, the
usual variance estimator performs very poorly in detecting the true variance of θ and
underestimates the true value. Additionally, the actual variability of the variance esti-
mator is always higher than both the optimal and declared values, with a consequent
overstatement of the precision of the estimator and misleading results in the form of
Conﬁdence Intervals without correct coverage properties, in particular with small sam-
ple size studies.
The aim of this thesis was not only to illustrate via simulations what circumstances
87worsen the estimate of the variance of the overall estimator (variance structure across
studies at the patient level, number of studies, allocation per arm, study size) but also,
and more importantly, to investigate whether a diﬀerent method, which can be accu-
rate and ﬂexible at the same time, existed. In particular, an estimator whose variance
does not diverge substantially from the optimal value, both on average and in practice,
was sought and found to provide both more accurate statements about the precision of
the point estimate and conﬁdence intervals which are more likely to have the correct
nominal coverage probabilities.
The overall average number of patients per study plays an important role which appears
to be more important than the total number of patients in each single study. Moreover,
the allocation of patients per arm does not seem to be decisive for the estimated overall
variance of the estimator even though balanced allocation, as well as having roughly
the same amount of patients per study, yields better results. Furthermore, true to
form, the higher the average number of patients per arm, the closer the variance esti-
mator is to the optimal one. However, when small studies are combined, the σ2
i ’s are
less precise and this leads to severely unreliable results. The ordinary method is too
sensitive to individual study variances and is negatively biased when sizes are too small.
In order to overcome this problem, we decided to shrink the individual pooled estimates
towards a common value before calculating the variances. The shrinkage estimators for
the pooled variances prove to be particularly advantageous compared with conventional
approaches when a single study carries a disproportionate amount of weight and has
few subjects, which may indicate a very low sample variance just by chance. Borrowing
information across variances through the “modiﬁed CHQBC estimator” produced an
overall variance estimate whose ‘real’ and ‘average’ dispersion were both closer to the
optimal value, representing a reasonable alternative to the ordinary method. Results
obtained via simulations (with diﬀerent patterns for various variance schemes and di-
verse average numbers of patients per study), emphasised that the estimator of the
overall variance based on the ‘shrunk variances’ (ˆ V ∗), performed better than the one
based on the estimated sample variances (ˆ V ), minimising the real dispersion of the
overall variance estimator. Moreover, regardless of the variance structure across stud-
ies, ˆ V ∗ (calculated with the new proposed weighting scheme) performs optimally even
with a small average number of patients per trial, achieving almost optimal results
without relying on computationally expensive procedures.
As a consequence, since the overall variance of the point estimator was better esti-
mated with the proposed technique, the coverage probabilities of the approximate 95%
conﬁdence intervals based on ˆ V ∗ were found to be generally accurate, in that they were
88approximately equal to the nominal coverage value. The proposed weighting scheme
yields conﬁdence intervals with higher coverage probability than the commonly used
interval based on pooled variances, particularly when the number of studies is moderate
and the average number of patients per arm is small. In light of these results, ˆ V ∗ is
strongly recommended, since this appears to perform better than (or at least as well
as) the usual variance estimator across the range of cases, and this provides additional
protection against large errors in the estimated sample variances and hence in impre-
cisely estimated weights.
In this thesis we have shown the consequences of using the estimated weights in the cal-
culation of the overall variance of the common eﬀect estimator in combining estimates
from independent studies. We have pointed out that (ˆ V ) is not a good estimator for
the correct variance of the overall eﬀect estimate when the weights are merely based
on sample variances, as in practice. Protection against errors in the estimated weights
should therefore be provided. We recommend the use of the proposed weighting scheme
to achieve more reliable estimates of the overall variance and better approximations of
the nominal signiﬁcance level, which has the added advantage of simplicity. Due to its
easy application and its good performance in the simulation study, the proposed shrink-
age estimator for the pooled variances is a good alternative to the ordinary method.
The use of shrunk variances for the variance of an overall eﬀect estimate is advocated
in making inference for the ﬁxed-eﬀects meta-analysis, particularly when the studies
considered have, on average, a small number of subjects because of its more accurate
estimate of the overall variance.
Finally, it should be noted that this thesis has only considered the weighted mean
diﬀerence for continuous data. Many other outcome variables are possible when deal-
ing with the comparison of two treatments, control and experimental, in an eﬀort to
ﬁnd out whether there is a signiﬁcant diﬀerence between the two. Standardised mean
diﬀerence for continuous variables as well as odds ratio, diﬀerence or ratio of propor-
tions in the case of qualitative attributes play an important role to detect the eﬀect size
and measure such a diﬀerence. Nevertheless, no attempt has been made to assess the
precision of the estimators and to evaluate whether shrinkage estimators might improve
overall variance estimates in these cases as well. Further investigation and research are
needed in this area to evaluate whether shrinking the pooled variances before calcu-
lating the variances would be a superior method than the ordinary one for categorical
variables as well.
Another possible step would be to try an extension of the considered method to the
case of random-eﬀects models where we could observe the same deﬁciencies as in the
89the ﬁxed-eﬀects models considered above. Despite the fact that the problem of estimat-
ing σ2
i is particularly urgent and dramatic in the ﬁxed-eﬀects model, the estimation of
σ2
i might also be expected to inﬂuence random eﬀects coverage probabilities especially
when all studies in the meta-analysis are small (Brockwell & Gordon, 2001).
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